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Abstract

APPROACHES TO REDUCE SELECTION OF GENOMIC VARIANTS IN HUMAN
PLURIPOTENT STEM CELL CULTURE
By Marion Joseph Riggs, Ph.D.
A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor
of Philosophy at Virginia Commonwealth University.
Virginia Commonwealth University, 2014.
Director: Raj R. Rao
Associate Professor
Department of Chemical and Life Science Engineering
Department of Human and Molecular Genetics

Optimizing culture conditions that reduce genomic instability in human pluripotent
stem cells (hPSCs) is an unmet challenge in the field. Results from our lab and numerous
research groups demonstrate that hPSCs are prone to genomic aberrations and single-cell
passaging increases the rate of genomic alterations. However, single-cell based passaging
maintains advantages for scale-up and standardizing differentiation protocols. In this
study, we investigated the problem of genomic instability in hPSC cultures with the goal
towards identifying and characterizing candidate genes that could contribute to generation
and survival of abnormal hPSCs. Based on microarray analysis, we identify ARHGDIA,
located on 17q25, as a candidate gene conferring selective advantage to trisomy 17 hPSCs.
Using lentiviral approaches to overexpress ARHGDIA in hPSCs, [hPSC (Arg)], we

functionally validate that in enzymatically passaged co-cultures, hPSC (Arg) lines exhibit
competitive advantage against wild type hPSCs, [hPSC (WT)]. Additionally, hPSC (Arg)
lines exhibit increased single-cell survival at low density plating. In co-cultures with hPSC
(WT), ROCKi exposure attenuated the competitive advantage of hPSC (Arg)
subpopulations. For the first time, this work demonstrates that increased expression of a
gene on 17q25 confers selective advantage to hPSCs. In parallel studies, using medium
devoid of bFGF containing LIF plus two inhibitors, MEK inhibitor (PD0325901) and p38
inhibitor (SB203580), we demonstrate that hPSCs are LIF responsive and can be stably
maintained in naive pluripotent culture conditions. Based on their clonal viability, we
propose that naive hPSCs are a more genetically stable population than primed hPSCs,
when passaged as single- cells. These studies will aid the long-term goal of hPSC scale-up
while promoting stable propagation of genomically normal hPSCs.

CHAPTER 1
Introduction and Review of the Literature

1

1.1 Human Pluripotent Stem Cells: Origins and Characterization
Human pluripotent stem cells (hPSCs) have two defining qualities, limitless self-renewal;
and, the capacity to differentiate into each of the three embryonic germ layers: ectoderm,
endoderm, and mesoderm [1]. These unique properties of these hPSCs and their expansion
potential, has generated significant excitement in the scientific community and media for their
potential to be used as an off-the-shelf cell source for tissue replacement strategies, human tissue
models for toxicity testing and drug discovery, disease- in- the- dish modeling, and studying
early human development [2-4]. Human PSCs are classified according to their origin and method
of derivation [5]. Different origins for diploid pluripotent stem cells (PSCs) include: (a)
embryonic stem cells (ESCs) from the inner cell mass of blastocysts or epiblast [6], (b) Germline
cells including primordial germ cells (PGCs) [7], embryonic carcinoma cells (ECs) from
teratocarcinomas [8], and spermatogonial stem cells (SCCs) [5], (c) somatic cells that are
reprogrammed to a pluripotent state, called induced pluripotent stem cells (iPSCs) [9], and (d)
enucleated oocytes with transfer of a full complement of donor DNA via a process termed
somatic cell nuclear transfer (SCNT) [10].

While starting materials for hPSC derivation is highly varied from embryonic to adult tissue,
a common set of cell surface and intracellular markers characteristic of pluripotency is widely
accepted to indicate self-renewal capacity and differentiation potential [6, 9, 11]. An extensive
set of assays for gene and protein expression are routinely used to validate self-renewal. Selfrenewal can be tested at each passage; however, validating tri-lineage developmental potential
requires several weeks or more [12]. The pluripotent state is strongly defined by a core set of
transcription factors that include OCT4, NANOG, and SOX2. These transcription factors are so
2

tightly coupled with the pluripotent state that in somatic cells, forced expression of a set of four
transcription factors, including OCT4 and SOX2, is sufficient to reprogram somatic cells back to
the pluripotent state [9]. IPSCs have opened new horizons for studying the genetic basis of
disease in stem cell derived human tissue models from Mendelian based genetic disorders to
complex disorders like schizophrenia [13]. For the remainder of this review, we will restrict
hPSCs to mean either hESCs or iPSCs.

The first step in screening for hPSCs is morphological analysis which demonstrate that
undifferentiated hPSCs form tightly packed colonies with cobblestone morphology. Alkaline
phosphatase (AP) activity is a quick assay that can be conducted without any specialized
equipment, with positive activity indicative of an undifferentiated state [14, 15]. Extra-cellular
markers, SSEA3, SSEA4, Tra-1-60, Tra-1-81 can be readily used for flow-cytometry analysis or
sorting; and routinely, immunocytochemistry (ICC) is used for both intracellular and
extracellular protein identification. Commonly, quantitative real-time polymerase chain reaction
(QPCR) is used to demonstrate expression of the essential pluripotent stem cell transcription
factors, OCT4, SOX2, and NANOG. While these assays are limited to showing self-renewal,
differentiation potential for hPSCs can be demonstrated by either in vitro or in vivo
differentiation protocols, embryoid body (EB) formation in suspension cultures or teratoma
forming assay in mice, respectively [6, 12]. EB formation is most commonly performed using
the hanging drop method over a three week period [12, 15]. Teratoma forming assay takes 6-8
weeks requiring hPSCs to be injected into severe- combined immunodeficiency (SCID) mice in
the kidney capsule or the tail [6, 16].

3

Interestingly, while mouse embryonic stem cells (mESCs) and hESCs share many of the
same molecular features, there are clear differences. For example, mESCs express cell surface
marker SSEA1 but not SSEA-3/4; whereas, hPSCs do not express SSEA1 but express SSEA-3/4
[17]. Initially, these differences were attributed to species divergence [18]; however, a growing
body of work is demonstrating that PSCs are compartmentalized by a primed vs naïve
pluripotent stem cell state, human and mouse ESCs, respectively, are indicative of two different
in vivo counterparts [19-33]. The “naïve” state is similar to cells from the pre- implantation
epiblast, while the “primed” state is characteristic of post- implantation epiblast stem cells
(EpiSCs) [5, 24]. HESCs and mEpiSCs have been shown via key developmental markers to be
strikingly similar [31].

1.2 Naïve vs. Primed Human Pluripotent Stem Cell States
An emerging view is the existence of a transient ground state of pluripotency in epiblast cells
the form in the founder tissue of the embryo proper that during this developmental period
acquires the capacity to form all lineages and is distinct in potential from blastomeres and ICM
[24, 27, 28, 31, 34]. The egg and blastocyst only give rise to two cell types, trophoblast and ICM,
with the ICM then forming the hypoblast and epiblast. Thusly, Nichols and Smith argue the preimplantation epiblast is not a reduction in potency from totipotent cells but uniquely acquire an
unrestricted ground state of pluripotency, without developmental bias, that can form all
embryonic lineages [24]. Of significant question and active area of research is whether ESCs in
culture are true analogs of an in vivo developmental stage or are culture epiphenomena [25].
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Perpetual expression of pluripotency and the non-native cell culture environment invokes
continual pressure for genomic and epigenetic adaptations in hPSCs [27]. However recent
research is clarifying our view of pluripotency as comprised of different metastable states [35].
Notably, researchers have come to appreciate two different pluripotent stem cells states, “naïve”
and “primed” PSCs as they pertain to cell culture and their associated developmental analogs
[25]. The differences between mPSCs and hPSCs are now attributed to their occupation in these
two different states, as opposed to species divergence [31]. Mouse PSCs are naïve pluripotent
stem cells akin to the pre-implantation epibast; whereas hPSCs are in a primed state consistent
with post-implantation epiblast of mice, mouse epiblast stem cells (mEpiSCs) [36]. Naïve
pluripotency and the “ground state” are highly similar; however, the ground state in mice has
been shown to have the additional characteristic of growth factor independence, and to simply
rely on the inhibition of differentiation cues [23, 29]. In mice, culture conditions for mPSCs have
been established to recapitulate the ground state of pluripotency and most similarly mirror the in
vivo ESCs of the pre- implantation epiblast [29]. Progress has been made on developing culture
conditions to support naïve hPSC culture; however, identifying the signaling for capturing the
ground state in hPSCs remains a significant scientific hurdle [20, 31, 37].

The establishment of mEpiSCs has enabled researchers with a comparison model for
hPSCs; and significant similarities strongly support the view that hPSCs exist in the primed
pluripotent state [38, 39]. A striking cell culture similarity is the reliance of both mEpiSCs and
hPSCs on basic fibroblast growth factor (bFGF) to promote self-renewal; while, mPSCs are
leukemia inhibitory factor (LIF) responsive for stem cell maintenance [27, 31, 40, 41].
Therefore, bFGF is associated with maintaining primed pluripotency and LIF for supporting
5

naïve pluripotency. LIF is a member of the interleukin-6 cytokine family with a transmembrane
glycoprotein, GP130, which heterodimerizes with LIF receptor β (LIFrβ) to activate downstream
transcription factor, STAT3, to promote self- renewal in mPSCs [42]. It is of considerable
significance to develop culture conditions for the derivation and propagation of naïve hPSC lines
and further towards that goal, establishment of the ground state for hPSCs. The difference
between naïve and primed PSCs has significant biological and technical implications for their
full realization in basic research and clinical applications. While hPSCs have been most exciting
since their initial derivation in 1998, several technical facets in comparison to mPSCs have
impeded their use in biomedical research.

The scale- up of hPSCs is a challenge compared to mPSCs, since mPSCs have a much
higher population doubling time than hPSCs [43]. This is because mPSCs have faster cell cycle
times [44] and high clonal survival at plating [45]. Where hPSCs can be expanded at 10- fold per
week, mPSCs can be expanded at 1000- fold per week [43]. A longer G1 phase was determined
in mEpiSCs compared to mPSCs, suggesting that establishing naïve culture conditions may
result in reduced cell cycle times for primed hPSCs, as well [46]. HPSCs are heterogeneous in
their expression of pluripotent genes with consequent variation in self-renewal likelihood [47,
48]. As well, hPSCs demonstrate differentiation bias with variable propensity for different
lineages, this may indicate prior specificity that is attributed to their post-implantation epiblastlike primed state [25, 49]. Whereas, naïve stem cells and in particular, ground state stem cells are
believed to have greater homogeneity and unrestricted lineage potential [27]. Ground state
establishment in hiPSC lines has significant practical implications for overcoming limitations in
their differentiation potential [50]. In contrast to mPSCs, hPSCs are not amenable to homologous
6

recombination (HR), and this has significantly hindered genetic engineering of hPSCs to model
disease and development, as well as gene correction in iPSCs [30, 31]. Buecker and colleagues
have reported the development of naïve- state like hiPSCs by 5 reprogramming factors and LIFbased culture conditions that enabled HR of the hPSCs. While these hPSCs self-renewed, they
lost their differentiation capacity, suggesting further work is needed to develop true naïve hPSCs;
however, this is a promising sign that HR amenable hPSCs is possible in the naïve state [51].
MPSCs can be simply maintained on gelatin, whereas hPSCs require feeder cells or elaborate
protein-based substrates. Recently, in medium containing soluble fibronectin and ROCK
inhibitor, Y-27632, single- cell hPSCs were successfully cultured on gelatin [52]. While adding
ROCKi and fibronectin to medium doesn’t necessarily reduce culture complexity or costs, it is
tantalizing to consider that culturing hPSCs in the ground state will reduce hPSC culture
complexity and costs by enabling expansion on gelatin alone.

Key differences in intracellular signaling between naïve and primed pluripotency have
been determined; however, the expression of the core transcription factor circuitry of OCT4,
SOX2, NANOG is conserved. Through iPSC research, it is appreciated that the expression of
key transcription factors, including OCT4 and SOX2 are masters of pluripotency capable of
reprogramming a somatic cell back to a pluripotent state [9, 27]. OCT4 and SOX2 are both
essential regulators of self-renewal and are independently post-implantation lethal in null mice.
OCT4 is essential for both hypoblast and epiblast formation [24]. OCT4 heterodimerizes with
SOX2 and together they bind their own promoters for autoregulation and a recursive selfreinforcing circuit, and together bind other pluripotency and development associated genes, for
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co-regulation [27, 42]. Along with promoting self-renewal, in mPSCs, OCT4 and SOX2 initiate
the differentiation process by driving the expression of the FGF4 signaling [27].

A role for NANOG in de novo establishment of the ground state is emerging. Unlike
OCT4, NANOG is only expressed in the epiblast [24, 53]. Forced expression of NANOG
obviates LIF requirement [54]; however NANOG- null mESCs continue to self-renew, even
though the embryos are post-implantation lethal [55]. NANOG co-localizes with OCT4 and
SOX2 at transcriptional binding sites [42, 56]. In the ground state, NANOG may act by
“buffering” FGF4-ERK signaling [27]. Bi-allelic expression of NANOG is a marker for the
ground state of pluripotency in contrast to naïve pluripotency [22]. FGF4-ERK regulates allelic
expression of NANOG, while inhibiting FGF-ERK leads to bi-allelic expression of NANOG and
the poor development of ICM in heterozygous NANOG expressing mice [22]. Together, these
findings support a critical role for NANOG in epiblast formation and ground state pluripotency.
During iPSC generation, NANOG’s essential developmental role in establishing pluripotent stem
cells is recapitulated [26]. In murine embryos, FGF4-ERK inhibition abrogates hypoblast
development, as measured by GATA6, and promotes all cells to form NANOG expressing
epiblast cells [23]. In mPSC lines, differentiation is initiated by auto-inductive FGF4 signaling
on downstream effector ERK1/2; therefore, inhibiting FGF4-ERK signaling prevents
differentiation in vivo and in vitro [29]. This suggests that pluripotency is inherently stable and
self- maintaining if the effects of extrinsic stimuli are neutralized, and that inhibition of FGF4 is
critical to capturing the ground state and the most developmentally authentic embryonic stem
cells [28].
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Finally, in 2008, after decades of research, mPSC cell culture converged to a stable point
with the establishment of culture conditions that maintained mPSCs in the ground state of
pluripotency. While a good review on the evolution of mPSC culture has been published by Blair
and colleagues as well as a comparative study on mPSC culture protocols [57, 58], we will
briefly summarize the critical advancements mPSC culture and their significance, for the purpose
of understanding the current state and establishing a roadmap for hPSC culture. Like hESCs,
mESCs were first grown on iMEFs [59], with further studies indicating that iMEFs secrete LIF
and that extrinsic stimulation of STAT3 by LIF supplemented medium was sufficient to replace
the iMEF feeder cell layer with simple gelatin coating [60]. Inhibitor of differentiation (ID)
proteins present in serum were determined replaceable by BMP-4 and N2B27 containing
medium; thereby, establishing a chemically- defined culture system, without the unknown
components of serum and a feeder layer [61, 62]. As in mPSCs, establishing defined hPSC
culture conditions has been an important goal and is an ongoing research effort of many labs [63,
64]. Remarkably, it was determined that only two inhibitors are needed to culture mPSCs in the
ground state. These two inhibitors are a highly specific MEK inhibitor (PD0325901) and
GSK3inhibitor (CHIR99021) [23, 28, 29, 65]. In the presence of these two inhibitors, LIF is
not necessary for mPSC self- renewal; however, LIF also promotes mPSC growth and viability,
thus the preferred ground state cocktail has been established as LIF + MEKi + GSK3i (LIF + 2i).
The MEKi inhibits the FGF4-ERK signaling cascade and GSK3i works through WNT signaling
and stabilization of intracellular β-catenin, [27, 66].

The ground state is a significant advance for being able to generalize the rodent system
among genetic strains, to the rat-species, increase phenotypic homogeneity of fully unrestricted
9

pluripotent cells, and generate the most authentic embryonic stem cells. Since the initial
derivation of mESCs, much of the research has involved a single genetic strain, 129; since, other
mouse strains were recalcitrant to mESC line establishment [67, 68]. Using ground state culture
conditions, LIF + 2i (GSK3), mPSC lines were derived from non-permissive mouse genetic
strains, NOD, C57Bl6, CBA, and FVB ES, as well as, the first germline competent rat ES cells
were derived [31, 69, 70]. Generalization of conditions for derivation of rodent pluripotent stem
cell lines is strongly supportive that a ground state of pluripotency exists and has been achieved
in murine culture; furthermore, that through inhibition of the FGF4-ERK axis, this ground state
is a perpetual and intrinsically sustained fate choice for mPSCs [27]. Recent work has made
advances in establishing culture conditions to support naïve hPSCs; but, the signaling network
for the hPSC ground state is unknown and furthermore may have significant species- specific
differences [40].

Rodents exhibit the phenomena of diapause, in which, blastocysts in suckling mothers
hatch to form the epiblast and hypoblast but the blastocysts fails to progress to implantation until
estrogen is restored [71]. During diapause the epiblast cells remain in the naïve state and are
LIF/STAT3/GP130 dependent [72]. During early embryogenesis, gene targeting on the LIF
signaling proteins did not influence self-renewal, but GP130- null mice cannot maintain
pluripotency during diapause [42]. Thus, the role of LIF may be developmentally restricted to
this potential for diapause. Diapause in rodents and this LIF responsive state has been shown to
facilitate the derivation of naïve mPSC lines [73]. So far, in mammals without diapause, true
ESCs have not been established [40]. This may suggest difficulty in establishing naïve and/or
ground state hPSCs, especially if the human epiblast cells are unresponsive to LIF/STAT3 [24].
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However, if epiblast and embryonic stem cell pluripotency are founded on a common ground
state, then this is expected to be conserved between mammalian species [27]. Nichols and
colleagues found when human IVF embryos are cultured in FGF-ERK inhibitors or in MEKi +
GSK3i, the epiblast maintains NANOG expression. This would not be expected in a primed
embryonic stem cell state, suggesting a naïve pluripotent epiblast and ground state exists during
human embryogenesis [31]. Recently, diapause was induced in sheep, even though sheep do not
normally exhibit diapause, suggesting that diapause may be an evolutionary conserved
phenomena in mammals with only some animals expressing diapause, such as mice [74, 75].

Strategies to generate naïve hPSCs include direct derivation from pre-implantation
embryos, reprogramming somatic cells to naïve pluripotency, and novel culture conditions that
can revert primed hPSCs to naïve hPSCs and support continued naïve hPSC propagation [31].
Each of these approaches has been successful in mice. In reprogramming of mPSCs, naïve vs
primed state pluripotency is cytokine dependent on LIF or bFGF, respectively, suggesting that
culture conditions are sufficient to determine pluripotency state [31]. Progress has been made by
several groups in reprogramming naïve hPSCs with a combination of transcription factors, LIF,
inhibitors, and histone deacetylase (HDAC) inhibitors. However, none of the current approaches
have fully established naïve hPSCs [30]. Recently, Gafni and colleagues used a complex medium
formulation containing LIF and bFGF plus inhibitors, MEKi, GSK3B, p38i, and JNKi to culture
hPSCs that exhibited some of the characteristics of naïve pluripotent stem cells [20]. Ware and
colleagues used the MEKi and GSK3i, common to the ground state in mPSCs, but in the
presence of bFGF. In order to reverse the hPSCs from the primed to the naïve state, the cells
were “reverse toggled” using the HDAC inhibitors butyrate and suberoylanilide hydroxamic acid
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[37]. In each of these two studies using only culture medium, the hPSCs exhibited an X preinactivated state and formed well- differentiated teratomas. Interestingly, the simplest formula
published on naïve hPSC conversion, suggests simply using LIF plus MEKi PD0325901 and
p38i (SB203580) [45], wherein p38i was determined by a high throughput chemical screening.
While Xu and colleagues state the successful conversion of hPSCs to mouse- like hPSCs in this
LIF + 2i (p38) medium, there isn’t any presentation of data on the self- renewal or differentiation
of these naïve converted hPSCs [45].

A significant cell culture distinction between naïve and primed PSCs is their difference in
clonality, where in one week mPSCs can be expanded 1000 fold and comparatively hPSCs only
10 fold [43]. Recently, a molecular pathway explaining the pluripotent state dependency for
dissociation-induced apoptosis between mPSCs and hPSCs was demonstrated [76]. Ohgushi and
colleagues show RHO signaling activation upon loss of E-cadherin based cell-cell contact is
different between naïve and primed PSCs. Upon loss of E-cadherin-dependent intercellular
contact, primed PSCs are characterized by a high amount of active RHOA and low amount of
active RAC1. Thus, primed PSCs activate ROCK-induced blebbing and cell death upon
dissociation. Conversely, naïve PSCs are characterized by low active RHOA and high active
RAC1 and do not exhibit the same pathway induced cell death. They propose an upstream
epiblast state linked regulator that is an effector of both RHOA and RAC1 activation upon loss
of E-cadherin based cell- cell contact [76]. Xu and colleagues also show RHO signaling in
hPSCs is regulated by E- cadherin based cell- cell contact; and that upon single- cell dissociation,
mPSCs have stable E-cadherin expression- attributed to decreased intracellular turnover- and
exhibit minimal RHOA activation, thereby explaining the robust clonality of naïve PSCs [45]. A
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morphological distinction between mPSCs and hPSCs are the small, compact, and dome- shaped
colonies of naïve PSCs compared to flatter and more spread out colonies of primed PSCs [37].
Table 1 summarizes molecular differences between ground state PSCs, naïve PSCs, and primed
PSCs relevant to this report.
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Table 1 Metastable pluripotent stem cell states profile
Marker
Ground State
Naïve

Primed

Cytokine

Independent

LIF, BMP4

bFGF, Activin A

Inhibitors

MEKi, GSK3

Serum (ID)

ROCKi

Clonal

Yes

Yes

No

Compact, Multilayer,

Compact, Multilayer,

Spread out, Flattened,

Cobblestone

Cobblestone

Cobblestone

KLF4 (high),

KLF4 (high),

KLF4 (low),

KLF2 (high), NANOG,

KLF2 (high), NANOG,

KLF2 (low), NANOG,

OCT4, SOX2

OCT4, SOX2

OCT4, SOX2

SSEA1, AP

SSEA1, AP

SSEA3/4, AP

E-cadherin

E-cadherin

Morphology

Transcription
Factors
Cell Surface

-integrin 1

ECM
Adhesion
Substrate

Epigenetic

E-cadherin
Gelatin

Gelatin

BD Matrigel™

Both X- active (female)

Both X- active (female)

One X- inactive (female)

Biallelic NANOG

Monoallelic NANOG

Monoallelic NANOG

expression

expression

expression

Ground state, naïve, and primed pluripotency exhibit differential expression of cell surface
markers, transcription factors, epigenetic modifications, and have different cytokine growth
factor requirements. Abbreviations: ID- inhibitor of differentiation proteins, AP- Alkaline
Phosphatase.
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1.3 Culture of Human Pluripotent Stem Cells

Current inefficiencies in successful implantation during assisted reproductive technologies
(ART) necessitates the generation of excess in vitro fertilization (IVF) embryos [77]. hESC lines
that are part of the NIH stem cell registry are derived from the inner cell mass (ICM) of donated
IVF embryos under informed consent and are no longer intended for reproductive purposes [78].
Pluripotency, in vivo, is acquired during ICM formation and is a transient in the epiblast cells of
the embryo proper [27]. However, hESC lines maintain pluripotency indefinitely and have
successfully been cultured for months to years [79-81]. Maintaining the pluripotent state during
long-term propagation puts strong selective pressure for culture adaptation that includes changes
in genomic DNA, mitochondrial DNA, epigenetic modifications, and protein networks [82-86].

Nearly a decade of scientific investigation identifying genomic alterations during hPSC
culture has established the recurrent genomic aberrations during culture and has culminated in a
comprehensive library of numerical, structural, and copy number variations [87-90]. In spite of
the substantial progress in identifying genomic alterations, little is known about the impact of
mechanisms known to cause mutation in somatic cells; and, even less is known about the
genotype to phenotype relationship that accounts for selection of genomic variants. To date, the
causative genes and signaling network responsible for selection of common genomic alterations
has not been determined and remains elusive [87]. Confounding the issue is a report that hPSCs
can express phenotypic features of neoplastic progression in absence of large scale chromosomal
changes but in simply upon small-scale copy number variations (CNVs) [91]. Culture adaptation
is an integration of two separate processes, causative mechanisms that result in a genomic
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alteration and culture selection of genomic variant cells with phenotypic advantage [92]. A
hallmark of culture adaptation is increased self-renewal but reduced differentiation capacity [9396]. Since extended culture is a parameter for culture adaptation, it is difficult to parse the basis
for reduced differentiation capacity, as resulting from changes in DNA or adaptive gene
networks to the culture environment. Theoretical considerations are particularly interesting on
this phenomena, as attractor state theory may suggest that continual selection will increase the
“basin of attraction” of the pluripotent state; and therefore, increase the energy barrier to
differentiation, as opposed to a reduced capacity for differentiation [29, 97]. Strikingly, it has
been reported that differentiation can select for some genomic alterations [88]. Potentially, a
significant cause for concern as we move towards using cells for therapies, but also interesting
developmentally and in disease pathology [98-101]. With chromosomal abnormalities being a
hallmark of cancer, it is of clinical importance that we maintain karyotypically normal hPSCs
(Figure 1) [92, 94, 95, 102].

In recent years, a preponderance of data is painting a picture of the intrinsic chromosomal
instability (CIN) of cells during early embryonic development and of hPSCs in vitro [103-106].
Reducing the mutation rate of hPSCs is an important strategy for stably propagating genomically
normal culture populations [107]. However, it is well appreciated by academia and industry that
in vitro conditions are sub-optimal and induce significant pressure for selection of genomic
alterations that increase clonality, proliferation, self-renewal, and anti- apoptosis [84, 87, 88, 92,
108]. For scale-up of sufficient cell numbers to be used in clinical applications, hPSC viability
remains a pressing concern [64, 109]. Human pluripotent stem cells are known for high rates of
apoptosis that can be influenced by culture conditions and passaging protocols [43]. Unlike
16

Figure 1. Genomic abnormalities in hESCs are similar to those seen in hECs. Trisomy 12
and 17 are commonly observed in hESCs and these genomic alterations are characteristic to
germ cell tumors and hECs and pose clinical concern for cellular therapies. Abbreviations:
hESC- human embryonic stem cells, hEC- human embryonic carcinoma cells.
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mPSCs, hPSCs are prone to cell death upon loss of cell- cell contact that occurs during
enzymatic dissociation of colonies into single- cells [45, 76]. The disruption of e-cadherin
junctions induces actin- based cytoskeletal changes through RHOA activation of the
kinase,ROCK. ROCK phosphorylates myosin light chain (MLC) to induce blebbing associated
cell- death through hyperactive actin- myosin contraction [110]. ROCK inhibitors, such as
Y27632, are commonly used to reduce cytoplasmic blebbing and improve hPSC survival at
passaging, cryopreservation, and thawing [109, 111]. Manual passaging maintains e-cadherin
based cell- cell contact improving cell viability at plating, while manually maintained cultures
[76, 112], also, exhibit a lower prevalence of genomic alterations during prolonged propagation
[82]. However, manual passaging is not amenable to scale- up [3]. HPSCs plated as single- cells
exhibit poor survival and increased genomic instability during serial passage; however, in
principle, single- cell plating is the most promising approach for scale-up and standardizing
optimized differentiation protocols [45, 64, 113]. The increased genomic instability of hPSC
single- cell cultures is consistent with the hypothesis of selection on survival and clonality [87].

Adherent culture conditions for hPSCs are complex and the essential components are
conserved for hiPSCs and hESCs. The general requirements of hPSC culture are basal medium,
medium supplements such as amino acids, serum or serum replacement factors for viability and
proliferation, feeder cell- layer or feeder-free substrates to support attachment, growth factors to
support stem cell self-renewal, and optional small molecules to support viability and inhibit
differentiation. Similar to the evolution of mPSC culture, optimizing hPSC culture conditions
remains a significant research challenge; however, several milestones in hPSC culture have been
achieved. The modest goal of industry is to reach scale- up of hPSCs in fully defined conditions
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that reduce variability and increase standardization of protocols. Clinical applications will
warrant xeno- free conditions and genomically normal cell products [2, 3, 80]. Two significant
advances in hPSC culture has been the development of knock-out serum replacement (KSR) and
Matrigel™ [111, 114]. KSR is a proprietary, commercially available defined formulation that
replaces fetal bovine serum (FBS) and has been critical step to developing fully defined culture
conditions. Matrigel™ is a non-defined xenogeneic substrate that eliminates the need for a
supportive inactivated mouse embryonic fibroblast feeder layer (iMEF) when used in
conjunction with iMEF conditioned medium or a specialty medium such as, Essential 8™ [115].
However, Matrigel™ does not meet the goal of establishing fully defined humanized conditions.
Abraham and colleagues have developed a non- xenogeneic feeder- free substrate by
decellularizing human foreskin fibroblasts and have extensively its usefulness in developing
‘humanized’ conditions for hPSC culture [116]. Recently, Primorigen Biosciences launched a
defined and xeno- free substrate, Vitronectin XF™, but similar to Matrigel™, this substrate does
not support clonal passaging, and thusly is amenable to manual passaging or as dissociated small
clumps in split ratios between 1:6 and 1:12. BioLamina commercially provides a xeno- free and
defined substrate, LN- 521™, which is a laminin isoform, expressed in the ICM that supports
single- cell plating at split ratios up to 1:30. However, laminins are hetero-trimeric proteins that
are costly to produce and difficult to purify [113]. The cost of LN-521™ at $1,374 per 1mg
compared to $80 for 1mg of Vitronectin XF™ makes routine use of LN- 521™ cost- prohibitive
and a non- pragmatic substrate- based solution for culture viability, for the foreseeable future.
Recently a chemically defined and xeno- free LN-521/E- cadherin matrix was reported to
support clonal hPSC culture [64]. Interestingly this matrix was successfully used to clonally
derive a hESC line, for the first time, from biopsy of a single blastomere from an 8-cell embryo.
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Significantly, the addition of e-cadherin to LN- 521™ is critical to the single- cell clonal
survival, as LN- 521™ alone has been determined to improve single- cell plating by increasing
the migration of hESCs to promote cell- cell contact [64]. Development of culture conditions that
support propagation of naïve hPSCs may provide novel cost- effective solutions that improve
survival, increase proliferation rates, and reduce protein matrix dependency.

Research on suspension and three dimensional culture systems that more accurately mimic in
vivo biology is very active [63]. It has been hypothesized that 3 dimensional culture will improve
stable propagation of genomically normal hPSCs by presenting a more natural environment that
reduces artificial selection. While this is a reasonable assumption, to date, there isn’t any data or
published study on the beneficial impact of 3-D culture in reducing the presence of genomic
aberrations during continued propagation. Current approaches to study cell- culture influences on
genomic instability are problematic. Efficient assays for such analysis are non-existent [113] and
experimental designs entailing long term culture is prohibitive. However, defined genetically
engineered lines with competitive advantage may enable investigating selection dynamics in
various culture conditions on an amenable time- scale for statistical analysis. High throughput
single- cell assays on genomic instability will be a significant advance for comparing mutation
pressure across varying conditions [117, 118].

1.4 Genomic Instability During Early Embryonic Development
Chromosomal mosaicism is highly prevalent during early embryonic development. Embryos
are classified as: (a) diploid- where all cells of the embryo are euploid, (b) aneuploid- all cells are
define by the same genomic aberration, (c) diploid- aneuploid- where some cells are euploid and
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other cells are of the same or multiple aneuploidies, or (d) aneuploid mosaic- where all cells
exhibit aneuploidy [104]. Chaotic embryos refer to aneuploid mosaics with greater than three
distinct aneuplodies [119, 120]. In 1978, the world witnessed the first birth of a baby conceived
in the laboratory using in vitro fertilization (IVF) [121]. Pre-implantation genetic screening
(PGS) is a process where 1-2 cells are taken from a blastomere of a morula stage IVF embryo to
test for the genetic make-up [122]. Advances in molecular and cytogenetic approaches are
enabling researchers to profile the human genome during early development at unprecedented
resolution and specificity [123, 124]. Cytogenetics, traditionally performed via conventional gband karyotyping, spectral-karyotyping, or fluorescent in situ hybridization (FISH) has been
further empowered by advances in single- cell genomic technologies. With cellular precision we
can interrogate the human genome using high through put technologies, such as array
comparative genomic hybridization (aCGH), single nucleotide polymorphism (SNP) arrays, and
deep sequencing from amplified DNA from a single- cell [125, 126]. The application of singlecell approaches has become increasingly apparent as chromosomal mosaicism is highly prevalent
during cleavage stage embryos [127, 128].

Compared to other mammalian species human embryos have an order of magnitude higher
prevalence of aneuploidy [129]. Sixty-five percent of spontaneous miscarriages have
chromosomal abnormalities [104] and only 30% of conceptions result in live-birth. This suggests
that CIN is a significant barrier to successful reproduction and that data from IVF embryos is
also mirrored in pregnancies [130]. Errors from meiosis have two distinct features compared to
mitotic-based errors: (a) uninform throughout embryo [131] and (b) maybe more resistant to selfcorrection at the peri-implantation stage [124, 132]. For our purposes of elucidating genomic
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instability in hPSC culture, we emphasize mitotic-based mechanisms. PSCs have a characteristic
cell cycle profile distinct from somatic cells. A shortened G1 phase of the cell cycle and absence
of interphase and mitotic cell cycle checkpoints may explain the high rate of CIN during early
development [44, 133-135]. For the first 3 days, until compaction, the post-zygotic embryo relies
on maternal mRNA for cellular instruction, upon which it activates its own genome [104].
Vanneste and colleagues report that at day 3, 91% of cleavage stage embryos had at least one
aneuploid cell [105] and only 49% contain any normal diploid blastomeres [136]. Blastocyst
stage embryos carry a high degree of chromosomal abnormalities; however, the proportion of
abnormalities decreases from the cleavage to the blastocyst stages, indicating negative selection
by the time of peri-implantation [130]. In a study of 1,290 embryos using aCGH, 56% of
blastocysts were classified as chromosomally abnormal, including meiotic and mitotic
originations. Of this 56%, ~30% of the blastocysts were aneuploid mosaic and diploid- aneuploid
mosaic, indicative of mitotic instability during early cell divisions. Of the diploid-aneuploid
mosaics only 9% are greater than 33% euploid. With this low percentage of euploid cells in
diploid-aneuploid mosaic it is unlikely these embryos are peri-implantation viable Figure 2
[104].

Dekel-Naftali and colleagues report the following percentages of chromosomally normal IVF
embryos during 0-13 days of culture. On day three, 31.1% of embryos were classified as normal
and by day 6 the percentage increased to 45.0. The trend continued on day 7 to 57.1%; and, on
days 8-13 the average percent normal was 52.6% [130]. The data from both studies suggests
aneuploidy is selected against throughout early development. The types of genomic alterations
observed in mosaics are similar to those seen in children born with developmental disorders and
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Figure 2 Chromosomal mosaicism in early embryonic development. Only 42% of preimplantation genetic screening embryos are euploid for all cells. Aneuploidy from mitotic errors
are very prominent in early development in up to 33% of embryos. The fraction of viable aneuploid
embryos is likely very low since only 9 percent have greater than 33% euploid cells. Figure is
adapted from Aneuploidy in the human blastocyst [104].
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those seen in cancer, suggesting a clinical significance to understanding the CIN of embryonic
stem cells [105]. Numerical and structural abnormalities are common. In cleavage- stage embryos,
Mertzanidou and colleagues found that 70% contained large-scale structural chromosomal
alterations [123]. Two large independent studies differed on the frequency of monosomy compared
to trisomy, but the tendency is to report a higher prevalence of monosomy in aneuploid preimplantation embryos [124, 137]. Post-zygotic mitotic errors are commonly caused by anaphase
lagging and can also result from mitotic nondisjunction [130]. Micronuclei formed from extruded
lagging chromosomes and are appreciably observed at cleavage stage embryos, validating the
prominence of this mechanisms in contributing to genomic instability in totipotent and pluripotent
cells [124]. Common to two studies, the most frequently observed aneuplodies of IVF embryos
are reported as chromosomes 22, 16, 15, and 21, [104, 124] respectively; however, recurrent
aneuploidies has not been observed at the pre-implantation stage [130].

Self-correction has been attributed to reducing the number of aneuploid embryos at the
blastocyst-stage and peri-implantation relative to cleavage embryo [122, 131]. Of the abnormal
embryos tested on day 3 by PGS, it was found that 35.5% became normal by the time of final
testing at developmental arrest [130]. Munne and colleagues report self-correction in aneuploid
embryos monitored at day 3, day 6, and day 12 post-implantation [138]. In 4 mosaic embryos with
an average of 12.5% normal cells on day 6, 47.8% were normal by day 12; thereby, supporting the
important role for post-blastocyst stage normalization in embryonic development [138]. Fragouli
and colleagues report a decrease in abnormalities per embryo from 3.3 at the cleavage stage to 1.1
in blastocyst cells [124]. The same mechanisms for genomic instability may account for selfcorrection, anaphase-lag, nondisjunction, or chromosome demolition [138]. It is likely that in
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diploid- aneuploid mosaic embryos, diploid cells during cleavage divide better than aneuploid cells
leading to disomic enrichment by day 5 [131]. Apoptosis and decreased viability of aneuploid cells
is another means for selection of disomic cells. In the blastocyst, apoptotic pathways are activated
and some aneuploid blastomeres undergo apoptosis [139]. Interestingly, reprogramming somatic
cells has demonstrated genomic mosaicism originating from adult cells, however their embryonic
origin is unknown [140, 141]. As well, healthy mitotic and post-mitotic neurons have been shown
to commonly exhibit aneuploidy [142-144] and genomic alterations during embryonic brain
development is increasingly speculated to cause adult neurological diseases, such as schizophrenia
[100, 101, 145].

Narwani and collagues derived 12 hESC lines from PGS- identified aneuploid blastocysts
containing trisomies 14, 15, or 18 and monosomies 14, 16, 18, or 21. Interestingly, all the
aneuploid- derived hESC lines were euploid; except, for one exception, the CSES14 line contained
a partial translocation of chromosome 17 to chromosome 7 with karyotype 46XX, t(7;17). The
authors show through polymorphic maker expression that euploidy was not established through
mitotic- based self-correction [146]. They propose in vitro selection favored euploid proliferation
[147] and conclude that aneuploid mosaic blastocysts can be used to establish normal euploid
hESC lines.

1.5 Genomic Instability of Human Pluripotent Stem Cells During Culture
Culture adaptation is the integration of two separate processes, mechanisms resulting in
genomic alterations and selection of genomic variant cells. Recent publications have underscored
the presence of chromosomal mosaicism in normal and abnormal hPSC lines [148] . Using FISH,
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Dekel-Naftali and colleagues demonstrated across 5 hPSC lines, hESC and iPSC, that normal
cultures exhibit low- grade mosaic aneuploidy. Probing hESCs for chromosomes 12, 13, 16, 17,
18, 21, X, and Y, it was determined that hESCs had a statistically significant increase in
aneuploidy compared with amniotic fluid cell controls. Both iPSCs and hESCs exhibited
increased aneuploidy percentages over time in culture. Per chromosome, gains and losses
appeared stochastic; however, monosomy was found more often than trisomy, a characteristic
not often reflected in recurrent hPSC genomic alterations. The average aneuploidy rate per
chromosome was found to be 1.3% (+/- .6), suggesting an expectation of 29.9% of cells in any
given culture to contain an aneuploidy [148].

Peterson and colleagues propose that mosaic aneuploidy is a normal characteristic of hPSCs
that may help explain the phenotypic heterogeneity of hPSC lines. Their extensive analysis on 6
hESC lines and 1 iPSC lines at early passage (<p50) demonstrate a significant presence of
aneuploidy and preference for monosomy compare to trisomy, with common exhibition of
hypoploidy. By conventional g-band scoring, the monosomies could be misconstrued as artifact;
however, the high presence of monosomies was confirmed by FISH. Their results showed that
within a given culture of hPSCs, between 18-35% of cells may be aneuploid. This percentage of
aneuploidy is consistent with observations by Dekel-Naftali and colleagues who found 1.3% per
chromosome were aneuploid. The presence of aneuploid mosaicism was independent of
laboratory, culture conditions, and passage number with chromosomal gains and losses observed
to be stochastic and non- clonal. They suggest chromosomal mosaicism may be a vital part of the
pluripotent state to “endow hPSC lines with fitness” for self-renewal and to respond to
environmental cues for differentiation [103].
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In 2012, Biancotti and colleagues, investigated 419 aneuploid PGS embryos to look at
patterns of monosomy and trisomy in vitro and found a total of 341 monosomies and 361
trisomies. Notably, a bias towards monosomy relative to trisomy as a whole or per chromosome
was not observed. However, some chromosomes were determined prone to numerical alterations.
Of the 12 chromosomes interrogated by FISH, chromosomes 8, 17, and 20 had the least
frequency of numerical alterations [106]. Chromosome 8 contains C-myc, a known oncogene
significant in reprogramming [9], and chromosome 17 and 20 are among the most frequently
observed abnormalities in culture [88]. Selection bias for trisomy was observed. hESC lines were
established from blastomeres exhibited trisomy for 13, 16, 17, 20, and 21; however, only one
hESC line from a monosomy blastomere for X could be generated, suggesting that monosomy is
deleterious for cell survival and development. Interestingly, trisomy 17 or 20 in blastomeres
increased the likelihood of hESC line establishment, indicating significant selective advantage
for these chromosomes. Viability difference between trisomy and monosomy is attributed to
gene expression and it is likely that 50% loss of gene expression is more deleterious than a 1.5
fold dosage increase [106].

Over the past decade, since the first report on the presence of chromosomal abnormalities in
hPSC culture, a significant amount of data has accumulated cataloguing recurrent abnormalities
and their relative frequency. Initial studies using g-band karyotyping have progressed in
technical capacity to high resolution SNP arrays, including two recent publications that analyzed
a total of 322 hPSC lines using Illumina 1M Quad SNP array technology [87, 88]. The most
frequently chromosomal abnormalities are chromosomes 1, 12, 17, 20, and X, with trisomy 17
being the most frequent aberration in our bibliographic review of 22 publications (Figure 3), and
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Figure 3 Distribution of Recurrent Chromosomes Alterations in hPSCs. 22 publications
were surveyed for numerical and structural chromosomal gains. Trisomy 17 is the most
commonly observed chromosomal alteration. “Other” is all chromosomes not specifically listed.
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in the International Stem Cell Initiative’s consortium study of 136 ethnically diverse hPSC lines
[87]. Along with chromosome 17 alterations, Laurent and colleagues report a high frequency of
copy number increases for chromosomes 12, 20, and X across 186 lines [88]. SNP arrays detect
post-selection clonal genomic alterations conferring phenotypic advantage; however, little is
known regarding the genes on these amplified loci and their phenotypic association. Small scale
duplications on chromosome 12 encompassing NANOG and/or the pseudogene NANOGP1 have
been observed, but so far, no functional relevance for selective advantage has been demonstrated
for either. Interestingly, a minimal amplicon for chromosome 20 at 20q11.21 has been widely
observed encompassing the gene BCL-XL. Recent reports have demonstrated a clear phenotypic
advantage for increased expression of BCL-XL in hPSCs and a driver mutator phenotype in
hPSCs has been suggested for this well- known oncogene [149-151]. Chromosome 17 is largely
characterized by numerical alterations but a minimal amplicon on 17q25 has been reported [87,
88, 92]. Currently, no reports have demonstrated a functional relevance for any gene to help
explain trisomy 17.

1.6 Mechanisms and Assays for Quantitating Genomic Instability in hPSC Cultures.
CIN and microsatellite instability (MIN) are largely reported as mutually exclusive events
[152]. Independently using the HPRT and APRT loci, researchers have been able to demonstrate
that ESCs have reduced base pair mutation compared to somatic cells [153]; and, hESCs are
associated with very robust DNA repair machinery [154-157]. Aneuploid- mosaicism is
prominent in IVF blastocysts, and hPSCs are prone to numerical and structural genomic
alterations [88, 103, 104, 130, 148]. Critical cell cycle checkpoints associated with protecting
against CIN are absent in hPSCs, such as the mitotic spindle assembly checkpoint and the
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decatenation checkpoint [134, 135]. Therefore, we decided to focus our efforts on quantitating
CIN in hPSC cultures. Culture conditions that influence CIN are largely unknown, but more
importantly assays to measure CIN in hPSC cultures are poorly developed and inefficient [113].
An efficient assay for quantitating CIN in hPSC cultures would meet the following criteria: (a)
high throughput, (b) devoid of any selection process, and (c) significantly capture the biology
underlying genomic alterations. To avoid selection dynamics, single- cell approaches are
requisite. High throughput assays have significant advantage in sensitivity and performing
statistical analysis. An ideal biomarker is one serving as a primary driver of CIN, by reducing
these events, the extended propagation of euploid populations should be improved.

Gisselsson proposes direct and indirect measures for assessing rate of CIN [158]. Direct
measures screen genomic content to ascertain mutation rate. Technical challenges can limit
resolution and specificity of genomic- based approaches, however advances in single- cell
genomics is enabling this approach to unparalleled detail [159]. Non-clonal G-banding, FISH,
and spectral karyotyping (SKY) can quantitate the amount of CIN at any given passage [160].
Each of these approaches are labor- intensive and require significant specialized training.
Indirect measures for CIN look at biomarkers associated with chromosomal alterations, such as
supernumerary centrosomes, micronuclei, anaphase bridges, and nuclear budding [158, 161]. A
leading cause of CIN is malsegregation of chromosomes during mitosis [162]; however, nuclear
budding during S- phase can expel excess DNA from the nucleus [163]. Micronuclei can form
from either of these mechanisms [164, 165]. Anaphase bridges form from telomere associated
break- fusion- bridge cycles [166]. Centrosomes coordinate the spindle apparatus of the
microtubule organizing center (MTOC) and are responsible for the faithful segregation of sister
30

chromatids into two daughter cells. Supernumerary centrosomes are a significant cause of
chromosome missegregation during mitosis and are an established mechanism for inducing CIN
through multipolar mitosis (Figure 4) [167]. Our lab took two approaches to quantitating the CIN
at any given passage in culture. We looked directly at non- clonal genomic alterations in two
lines at early and late passage. Secondly, we took an indirect approach by quantitating the
number of supernumerary centrosomes.
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Figure 4 Multipolar mitosis in hPSCs with supernumerary centrosomes. The BG01 hPSC line
was stained for centrosomes against pericentrin (red) (A), DAPI for nuclei (blue) (B), and -tubulin
for spindle assembly (green) (C). Normal bipolar mitosis consisting of 2 centrosomes (left arrow)
and abnormal tetrapolar mitosis with 4 centrosomes (right arrow) (D). Scale bar= 50m.
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1.7 Research Summary
After considering the above mentioned studies which clearly demonstrate the importance of
reducing genomic instability in culture, we investigated centrosome instability and a candidate
gene, ARHGDIA, hypothesized to confer selective advantage in single- cell culture. Our work
focuses on single- cell culture for its potential benefit in scale- up and standardizing
differentiation protocols. We found that single- cell culture can adversely influence centrosome
behavior during the initial culture transition by an unidentified mechanism. Further towards our
goal of studying culture adaptation, we overexpress this candidate gene to develop a genetically
defined biologically relevant selection model and demonstrate the application of our selection
system to hPSC cultures passaged as single- cells and exposed to ROCKi, Y27632. Building
upon the literature, we tested newly reported naive state hPSC culture conditions and
demonstrate LIF- responsiveness with successful long- term self- renewal and differentiation
capability. We propose that naive hPSCs may be a more genetically stable population by its
clonal advantage. This work is unique in demonstrating phenotypic advantage of a gene located
on chromosome 17 that may help explain the widespread observation of trisomy 17 in many labs.
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CHAPTER 2

The Role of ARHGDIA in Increasing Single- Cell Survival of Human Pluripotent Stem Cells
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ABSTRACT

Human pluripotent stem cells (hPSCs) have generated a lot of interest in the scientific
community based on their potential applications in regenerative medicine. However, numerous
research groups have continued to report a propensity for genomic alterations during hPSC
culture that poses concerns for basic research and clinical applications. Work from our laboratory
and others has demonstrated that amplification of chromosomal regions is correlated with
increased gene expression. To date, the phenotypic association of common genomic alterations
remains unclear and is a cause for concern during clinical use. In this study, we focus on a
common genomic aberration and a list of candidate genes with increased gene expression to
hypothesize a gene that may confer selective advantage when overexpressed. Our transduced
candidate gene overexpressing hPSC line exhibited culture dominance in co-cultures of modified
overexpression lines with non-overexpression lines. Furthermore, during low density seeding, we
demonstrate increased clonality of our overexpression line against matched controls. A striking
observation is that we could reduce this selective advantage by varying the hPSC culture
conditions with the addition of ROCKi. This work is unique in (a) demonstrating a novel gene
that confers selective advantage to hPSCs when overexpressed and may help explain a common

*

trisomy dominance, (b) providing a selection model for studying culture conditions that reduce
the appearance of genomically altered hPSCs, and (c) aiding in elucidation of a mechanism that
may act as a molecular switch during culture adaptation.
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INTRODUCTION

Human pluripotent stem cells (hPSCs) are defined by their ability to self-renew, undergo
tri-lineage differentiation, and maintain a normal karyotype [6]. However, earlier results from
our laboratory and others demonstrates a propensity for hPSCs to acquire abnormal genomic
signatures upon prolonged propagation [82, 87, 88]. Moreover, the presence of genomic
alterations can be increased by specific hPSC passaging methodologies [87, 168]. Two general
approaches to passaging hPSCs involves enzymatic dissociation into single- cells or manual
dissociation into small clumps. Small clumps of hPSCs maintain e-cadherin based cell-cell
contact which is critical to hPSC survival [76], while trypsinization of hPSCs results in cleavage
of the extracellular domain of e-cadherin, which undergoes time-dependent turnover [45].
Significant debate in the stem cell community exists on whether hPSCs should be passaged as
single cells or as small clumps. Ideally, hPSCs would be passaged as single-cells for the
following advantages: (a) increased numbers for scale-up, (b) standardization of directeddifferentiation protocols, and (c) clonal genetic manipulation [3, 43, 45]. While manual
dissection of hPSC colonies allows for selection of morphologically superior colonies, this
technique is time intensive and low throughput. Upon differentiation, lineage specificity is
influenced by the size of the initial cluster or number of cells [169, 170]. Uniformity from singlecell seeding and accurate cell counts are thus important steps for reproducibly controlling size of
aggregate formation and standardizing directed differentiation protocols [171, 172].
Unfortunately, increased genomic instability during single- cell passaging is a primary concern
for this approach and poor single-cell viability at seeding remains a significant barrier to large-
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scale production [87, 110]. In order to increase hPSC single cell survival at passaging, many
researchers have incorporated small molecules in the culture medium.

Inhibition of the RHOA-ROCK- pMLC pathway has been demonstrated to increase
hPSC single- cell survival [109]. Apoptosis from single-cell dissociation has been demonstrated
to be highly specific through the phosphorylation of MLC, by the kinase ROCK, inducing
blebbing associated cytoplasmic membrane rupture [110]. However, use of ROCK inhibitor
(ROCKi) in culture medium is of considerable debate, as reducing apoptosis could lead to
increased survival of genomically abnormal hPSCs, since apoptosis is a proposed mechanism for
purging cultures of cells with genomic damage [173, 174]. Since hPSCs exhibit high rates of
apoptosis and poor single- cell viability, strong selective pressure may exist for genomic
alterations that increase clonal survival and are anti-apoptotic [92]. The strong selection for
specific genomic species of hPSCs is evident by the common observance of particular genomic
alterations, such as 12, 17, 20, and X. This is highly suggestive that in culture adaptation,
comprised of both mutation and selection, selection is a particularly strong force in the
emergence of genomic variants [82]. Therefore, by improving culture conditions, we may be able
to reduce the selective pressure for genomic variants with phenotypic advantage.

Since hPSCs may be intrinsically characterized by a high degree of CIN, focusing on
reducing selection may be the ideal strategy in preserving the genetic integrity of hPSC cultures
[130, 175]. To date, the phenotype behind common and specific genomic alterations has been
unclear, and more specifically the functionally relevant genes located on these genomic loci
responsible for culture selection has remained elusive [87]. We have taken the approach of
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passaging hPSCs as single cells in order to: (a) reproducibly generate genomic abnormalities for
further study, (b) better understand single- cell passaging’s influence on genomic instability, and
(c) to determine conditions that may reduce genomic instability during single-cell passaging. The
long-term goal of this work is to improve scale-up of genomically normal hPSCs. Improving
single-cell culture of hPSCs while reducing genomic instability is of significant importance as
the regenerative medicine industry seeks to fill the need of supplying billions of cells for a single
regenerative medicine application [176]. Approaches for improving cultures inoculated with
single- cells target reducing: (a) cell death during single- cell plating, (b) spontaneous
differentiation during initial seeding, and (c) the presence of recurrent genomic alterations. We
hypothesize that increasing cell- viability will reduce selection of genomic variants and promote
the continued propagation of genomically normal hPSCs. This work is unique in demonstrating
(a) a novel gene that confers selective advantage to hPSCs when overexpressed and may help
explain a common trisomy dominance, (b) provide a selection model for studying culture
conditions that reduce the appearance of genomically altered hPSCs,
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METHODS
Human Pluripotent Stem Cell Culture
HPSCs were maintained on mitomycin C–inactivated mouse embryonic feeder (MEF)
layers in DMEM/F-12, 20% knockout serum replacement, 2 mM L-glutamine, 1% nonessential
amino acids, 50 U/mL penicillin, 50 microgram per mL streptomycin (all from
Gibco/Invitrogen), 0.1 mM beta mercaptoethanol (Sigma), and 4 ng/mL bFGF (Sigma). Cells
were enzymatically passaged via sequential dissociation using 1mg/ml type IV collagenase
(Gibco) and 0.05% trypsin–ethylene-diamine tetra-acetic acid (trypsin-EDTA, Invitrogen) or
manually passaged by fire-pulled pasteur pipette. hPSCs were replated on fresh feeder layers or
BD Matrigel™. Cells grown in BD Matrigel™ were coated at the lot specific recommended
dilution in 35mm plates. Medium was conditioned on iMEFS at 5 x 106 cells per T-75 flask for
24 hours up to day 10 from seeding.

Microarray Gene Expression Analysis
Statistical analysis was performed in the R environment. 6 HGU- 133A Affymetrix
microarrays comprising two classes, BG01v’s (aneuploid) and H9’s (euploid), were normalized
by cyclic loess and signal intensities summarized by GCRMA. Presence (P), marginal (M), and
absence (A) calls were determined using the MAS 5.0 detection algorithm. A gene was
considered for hypothesis testing, if it was considered present in either sample class. A gene was
considered present in either the normal or abnormal set if it was called present in at least two of
the three replicates. p-values were adjusted via Benjamini and Hochberg correction. Statistically
significant genes were determined at a FDR less than 0.05. Fold changes were calculated in
reference to the euploid sample arrays, such that positive fold change values reflect an increase
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in expression in the aneuploid class and negative fold changes an increase in the relative
expression of the normal class.

Chromosomal Distribution and Fold Change Calculation
Each probe set was annotated with chromosomal location via R using the hgu133a.db
library. A normalized ratio for each chromosome was plotted on a histogram, with the values
calculated by dividing the number of significant genes (either increased or decreased) by the
number of known probe sets for each respective chromosome. Probe sets considered present
among the normal class were considered for chromosomal fold change analysis. For each
chromosome, the mean across replicates was found for each gene, then the 0.2 trimmed mean
expression level of all genes for that chromosome was calculated, separately, for the normal and
abnormal samples. The fold change of abnormal to normal samples was then calculated, such
that positive fold change values reflect an increase in expression in the aneuploid class and
negative fold changes an increase in the relative expression of the normal class.

Ontology Analysis
Genes were compiled from the following four sources: Gene Ontology, Cancer Genome
Project, PluriNet [177], and Genomic Instability Set [178]. The Gene Ontology database was
queried for each ontology of interest by the GO ID using the GO ID/Term search. The entire list
of gene ontologies including children consists of 280 unique ontologies, translated in R from the
GO ID using the go.db library. From the Cancer Genome Project, all the genes of the “complete
working list” from the cancer gene consensus were included. Genes that were listed with an
associated cancer or syndrome were annotated under phenotype as cancer or cancer
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predisposition in our final gene list. Genes from the Genomic Instability set were listed as
genomic instability and their associated function were included. Genes from the PluriNet were
added and were annotated under phenotype as self-renewal. Ontologies were abbreviated and
the phenotype translated to cancer, cancer disposition, self-renewal, and genomic instability.
Significantly increased genes located on one of the trisomic chromosomes were then annotated
with ontology and phenotype.

Preparation of hPSCs for Karyotype Analysis
Human PSC cultured in T-25 flasks were subjected to cytogenetic karyotype analysis.
Cells were cultured to sub confluency with a growth medium change 24 hours before harvesting.
120 ng/mL of colcemid was added for 3 hours and 15 minutes at 37oC. Cells were rinsed with
HBSS–(Ca/Mg) and dissociated with 0.05% trypsin. Dislodged cells were centrifuged at
1000rpm for 8 minutes. The cell pellet was gently resuspended in 0.075 M KCl solution and
fixed in a solution containing 3:1 of methyl alcohol and glacial acetic acid at -20oC for 30
minutes followed by twice-repeated rinsing in fixative at 1000 rpm for 8 minutes. Cells were
stored in fixative at -20oC until analysis. Metaphases were spread on microscope slides, and
chromosomes were classified according to the International System for Human Cytogenetic
Nomenclature (ISCN) using the standard G banding technique. For non-clonal analysis, >50
metaphases were examined. For clonal g-banding, 20 metaphases for each sample were
examined.

41

Generation of ARHGDIA overexpression lines
For lentiviral generation, Glycerol stock of Precision LentiORF ARHGDIA w/ Stop
Codon (Open Biosystems) was stored at -80oC. 10 l of ARHGDIA glycerol stock was used to
inoculate 3-5 mls of LB Medium with ampicillin and agitated for 16 hours at 300 rpm at 37 oC. 1
ml was further diluted in 250 ml, shaken at 300 rpm and incubated another 24 h at 37 oC. The
plasmid was extracted using the Qiagen Maxi Prep kit by following the manufacturer’s
directions, and plasmid concentration quantitated using the BioMate3 UV-VIS
Spectrophotometer (Thermo Scientific, Waltham, MA). Lentivirus was generated using HEK293
cells on a 10 cm cell culture plate. 80% confluent HEK293 cultures were transfected with 10 g
of the ARHGDIA plasmid, 7.5 g of the packaging plasmid (psPAX2) (Addgene, MA), and 2.5
g of the envelope plasmid (pMD.2) (Addgene, MA) using Roche transfection reagent,
XtremeGENE 9. After 48 h exposure, the viral supernatant was collected, 0.45 m filtered, and
stored at 4oC for less than 24 hours. The viral supernatant was concentrated using the Lenti-X
concentrator (Clontech, CA) by following the manufacturer’s protocol. The concentrated virus
was resuspended in 500 l of DMEM/F12 medium and aliquotted for storage at -80oC . One 50
l aliquot was added to a 35mm petri dish containing hPSCs cultured on Matrigel™ or iMEFs
along with the addition of 6 g per ml of polybrene (Santa Cruz Biotechnology, CA). 24 hours
later, virus containing medium was exchanged with the hPSC growth medium. Subsequently, the
hPSCs monitored for GFP- positive expression by the Nikon Eclipse TE 2000-S inverted
microscope (Nikon, Melville, NY). GFP- positive colonies were marked by objective- marker
lens, manually selected, and propagated until use in experimentation.
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In vitro differentiation of hPSCs and histopathology of hPSC-derived embryoid bodies.
To generate embryoid bodies (EBs), hPSCs were dissociated using 0.05% Trypsin and
resuspended in growth medium without bFGF. EB formation was facilitated using suspension
culture by a hanging drop method, where cells at a density of 5,000 cells per 20 l drop were
suspended from a Petri dish lid in 50-100 droplets with the addition of 10 M ROCKi in the
culture medium. After 3 days, the surviving EBs were transferred onto agar plates at in 20 ml of
EB medium (hPSC growth medium without bFGF) to facilitate further differentiation with
medium changes every 2 days for a total differentiation duration of 15-20 days. EBs were
prepared for morphological analysis by fixation in 4.0% PFA in 1.5 mL microfuge tubes at 50100 EBs per tube. EBs were rinsed with PBS to remove PFA, resuspended in 200 L melted 4%
low melting point agarose (Sigma Aldrich) at 42oC, and incubated for 2 h to allow settling. Final
pelleting and agarose solidification were performed with brief room temperature centrifugation
at 500g. Agarose embedded samples were removed as single plugs and processed by dehydration
with increasing ethanol concentration to 100% followed by xylene and paraffination in a Leica
TP1020 tissue processor. Hematoxylin and Eosin (H and E) staining was performed on
microscope slide mounted 5 mm sections in a Leica Autostainer XL workstation (Leica
Microsystems, Richmond, IL). Images were acquired using an Olympus BX51 microscope
(Olympus, Center Valley, PA) using the default imaging parameters.

Antibodies and Immunocytochemical Analysis
HPSCs cultured on Matrigel™ or iMEFs in four chambered glass slides or cover slips in
35mm dishes were fixed via paraformaldehyde (PFA, 4%) in PBS or 80% Methanol.
Permeabilization for intracellular markers was achieved with 0.2% Triton X-100 in PBS. 3%
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normal goat serum was used for blocking and to dilute antibodies. Fixed cells were incubated
with primary antibodies: OCT4 (Santa Cruz Biotechnology, Santa Cruz, CA), SSEA4 (Millipore,
Temecula, CA), Pericentrin (Abcam), Beta-tubulin (Developmental Studies Hybridoma Bank),
ARHGDIA (Santa Cruz Biotechnology, Inc.). Goat anti-mouse IgG, anti- rabbit conjugated to
Alexa 488 or Alexa 594 (Molecular Probes, Eugene, OR) were used as secondary antibodies.
Centrosomes were visualized with percentrin and the spindle apparatus by -tubulin. Cells were
counterstained with DAPI (4'-6-diamidino-2-phenylindole). At 40x magnification, centrosomes
were counted per mitotic cell and the polarity recorded. Fluorescent images were acquired using
a Cool- Snap EZ camera (Photometrics, Tucson, AZ) mounted on a Nikon Eclipse TE 2000-S
inverted microscope (Nikon, Melville, NY) with NIS Elements BR software.

RNA isolation, real time reverse transcription quantitative polymerase chain reaction and
gene expression analysis
RNA was isolated from hPSCs using DNA/RNA All Prep (Qiagen) and quantified using
BioMate3 UV-VIS Spectrophotometer (Thermo Scientific, Waltham, MA) or Nanodrop 2000.
cDNA was synthesized from 1 mg of RNA using cDNA High Capacity reverse transcription kit
(Applied Biosystems, Foster City, CA). Transcriptional expression on various genes listed in
Table 6 were analyzed using quantitative real time RT-PCR (QPCR). QPCR was performed on a
Bio-Rad CFX96 Touch Real-Time PCR Detection System. Comparative gene expression
analysis (three replicates) was conducted using the CT or CT method depending on the
analysis and samples. GAPDH was used for normalization in all analyses. Relative gene
expression for hPSC experimental samples was assessed against hPSC controls and reported as
fold change and the student’s T- test used for statistical significance testing.
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Alkaline Phosphatase Assay
Staining for alkaline phosphatase was performed as per manufacturer instructions (Vector
Laboratories, Burlingame, CA). Briefly, the hPSCs were rinsed with deionized water to remove
traces of growth medium. The final solution was prepared by adding in order 2 drops of each
constituent to 200mM Tris HCl buffer, pH 8.5. The hPSCs were incubated in the final mixture
for 45 min in the dark and images were acquired using a Nikon DS-Fi1 camera mounted on a
Nikon TS100 Microscope (Nikon, Melville, NY).

Clonality Assay
For low-density survival assays, 1000 hPSC cells obtained after passing through a 40 m
filter were plated onto iMEFs in 35mm plates. To visualize hPSC colonies, cultures were stained
for alkaline phosphatase on Day 7 after initial seeding. The number of colonies were counted
using an inverted Nikon TS100 Microscope (Nikon, Melville, NY).

Competition Assay
HPSCs (Arg) and hPSC(WT) were maintained independently by manual passaging until
use in specific experiments. Upon initial enzymatic passage, cells were obtained after passing
through a 40 m filter and seeded at a mixed ratio of an estimated 70% hPSC(WT) and 30%
hPSC(WT) onto Matrigel™ or iMEFs. Cultures were serially passaged enzymatically and passed
through 40 m filter at each passage. The percent of ARHGDIA overexpressing cells at each
passage was quantitated by flow cytometry, using the Accuri C6 instrumentation. The percentage
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of GFP positive hPSCs was gated against similar plots of control hPSC (WT) cells under similar
cell culture handling.

Western Blot
At time of cell harvest and protein lysis, adherent cells were kept on ice and rinsed twice
with ice-cold PBS+/+ (containing 0.9 mMCaCl2, 0.52 mMMgCl2 and 0.16 mM MgSO4)
solution. After aspiration of the PBS+/+ solution, cells were lysed using the lysis buffer (Part#
GL36) with protease inhibitor from the G-lisa kit, Cat# BK124 (Cytoskeleton Inc., CO). Upon
addition of the lysis buffer, the cells were scraped, then spun down for 1.5 min at 11.6K rpm, and
snap frozen in liquid nitrogen followed by stored at -80oC. 20 l of the protein lysate was used to
quantitate the protein concentration using the Precision Red Assay (Cytoskeleton, Inc.).
For Western analysis, each lane on the gel was loaded with 30 g of protein sample.
Beta-tubulin (DSHB, Iowa) was used as the loading control. Proteins were separated by SDSPAGE and transferred onto nitrocellulose membranes (BioRad) for western blotting. The
membranes were exposed to primary antibodies at 1:500 to 1:2,000 dilutions at 4 oC overnight.
Specific protein bands were detected and quantified using infrared-emitting conjugated
secondary antibodies—anti-mouse 680 Alexa (Molecular Probes, Eugene, OR) or anti-rabbit
IRDYE 800 (Rockland Immunochemicals, Gilbertsville, PA). Blots were exposed to secondary
antibodies for 2 hours. Odyssey Infrared Imaging System and Image Studio Lite version 3.1 from
Li-Cor Biosciences (Lincoln, NE) was used for image capture and densitometric analysis. For
densitometric analysis, protein signal intensities were calculated and normalized against the
loading control protein using the signal intensity of the lane divided by the maximum intensity of
- tubulin as the normalization ratio.
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RESULTS

Clonal and Non- clonal Genomic Alterations Under Single- cell Passaging
For genomic instability studies and karyotypic analysis, we cultured four hPSC (H9, H1,
BG01(v), and iPSC) lines of different origin. Each line was routinely maintained on iMEFs and
were continuously cultured for greater than 25 passages. Previous work from our laboratory
generated the hyperdiploid line, BG01(v), with a complex karyotype containing trisomies on
autosomes 12, 14, 17, and an extra copy of the sex chromosome, X (Insert Reference). Using
similar methodologies, we enzymatically dissociated cultures into single- cells by sequential
exposure to collagenase followed by trypsin, denoted as CT throughout the remainder of this
document. Prior observations from our lab suggest that genomic abnormalities present after 25
consecutive enzymatic passages [82], so we initiated g-band karyotyping after this window of
continuous CT passaging. Karyotyping the BG01(v) line validated the existence of previously
reported genomic alterations on chromosomes 12, 14, 17, and X. Additionally, in the BG01(v)
cultures, a significant number of low-grade mosaics were observed for particular chromosomes.
Of the metaphase cells analyzed, trisomy 3 was present in 14%, trisomy 11 in 18%, trisomy 20 in
34%, and a derivative of chromosome 16 in 16% of the cells. The presence of distinct and highly
complex genomic species is suggestive of a high rate of genomic instability in the BG01(v) line.
Under continuous culture, the H9 line was karyotyped at two passages, passage 71 (CT-26) and
passage 150 (CT-105). The H9 line was aneuploid at passages 71 and 150. At passage 71, 67%
of the karyotyped H9 cell line were determined to be trisomy 17. At passage 150, g-band
analysis on the H9 cell line identified trisomy 12 and trisomy 17, suggesting an accumulation of
genomic alterations upon extended culture. The H9 associated trisomy 17 at passage 150,
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contained a deletion of p11.2. Trisomy 17 mosaicism of the H9 line at CT-26 suggests capture of
the initial culture dominance of this genomic species. It is likely that the trisomy 17 at passage
150 is the same one as the original trisomy 17 but had simply undergone a structural deletion.
The iPSC line, at passage 45 (CT-31), was trisomy for 17 and harbored a gain of X. The H1 line
was karyotyped at two enzymatic passage points, CT-29 and CT-58, passages 68 and 97,
respectively. While the initial H1- CT-29 sample was euploid, at CT-58, we found a previously
unreported structural gain on chromosome 15 at p11.2. The karyograms of hPSC genomic
alterations under single-cell passage are presented in Figure 5 and the genomic profile of the
hPSC lines is summarized in Table 2.
Non-clonal genomic alterations can indicate an increased rate of genomic instability by
inclusion of aberrations that are non-beneficial and do not undergo positive selection [160, 179].
Non-clonal g-band analysis, on a minimum of 50 metaphase spreads, was performed on the H9
line at passage 71 and the BG01(v) line. The BG01(v) line demonstrates a high presence of
random non-clonal genomic alterations, with 18 of 50 metaphase cells exhibiting a unique
genomic alteration (Table 3). In stark contrast to the observations in the BG01(v) sample,
random non-clonal aberrations in the H9 line at CT-26 were only observed in 3 of 52 metaphase
cells. This suggests that emergence of the competitive genomic species with trisomy 17 was not
paired with an increase in genomic instability, as measured by the presence of non-clonal
aberrations.
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Figure 5. Karyogram of 4 hPSC lines serially passaged as single cells. H9 line at passage 71
exhibiting trisomy 17 (A). BG01(v) line exhibiting multiple trisomies on 12, 14, 17, 20, and X and
a +der(16) (B). hiPSC exhibiting trisomy 17 and gain of X (C). H1 line with a segmental
duplication on 15p11.2 (D).
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Table 2 Clonal genomic abnormalities during serial single- cell culture
Cell Line

Passage #

CT #

Metaphase #

Karyotype (%)

H1

68

29

20 46, XY

H1

97

58

20 46, XY,add(15)(p11.2)

H9

71

26

52 47, XX, +17 (67)

H9

150

105

20 48, XX,+12,+del(17)(p11.2)
50, XXY (94); +3 (14); +11 (18); +12
(92); +14 (84); +17 (92); +20 (34);

BG01(v)

69

NR

50 +der(16) (16)

iPSC

45

31

20 48, XXY,+17

HPSCs dissociated as single cells and cultured on iMEFs. The H1 and H9 lines were continuously
passaged and karyotyped at two different passage points. H1 at passage 97 gained a segmental
duplication of 15p11.2. H9 at early enzymatic passage, CT-26, was 67 percent mosaic for trisomy
17 and subsequently gained an additional chromosome 12. BG01(v) exhibits hyper-diploidy and
culture mosaicism. The iPSC gained an X and chromosome 17. Non-clonal analysis was performed
on BG01(v) and H9 passage 71 lines, with 50 and 52 metaphase spreads analyzed, respectively.
The (%) is the percentage of cells in culture expressing the indicated genomic alteration.
Abbreviations: add- addition, del- deletion, der- derivative, CT- collagenase/trypsin passage, NRnot recorded.
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Table 3 Non- clonal karyotype analysis of hESCs exhibiting a unique genomic species
Cell Line

Metaphases

Mode

Range

Non-clonal (Range)

BG01(v)

50

50-51

44-58

18 of 50 (1-5)

H9p71 (CT-26)

52

47

37-48

3 of 52 (1)

The BG01(v) line demonstrates a high degree of genomic complexity with 18 of 50 metaphase
cells exhibiting a unique genomic complement. In the H9 sample, only 3 of 52 cells had a unique
genomic aberration. (Range) is the range on number of aberrations in the non- clonal cell. The
modal karyotype is listed. The chromosome range includes hypoploid hESCs, which
cytogeneticists most often attribute to a technical artifact; however, recently it was reported that
hypoploid hESCs are viable [103].
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Characterization of Centrosomal Amplification in hPSCs
Chromosomal instability (CIN) may be a hallmark of the PSC state. A high presence of
aneuploid- mosaicism is well documented in the blastocyst and recent studies have established
the prominence of CIN in hPSC culture [103, 104, 106, 124, 132, 175, 180]. Centrosomes are
critical mitotic machineries that act like bipolar pulleys responsible for the faithful segregation of
sister chromatids into two daughter cells during cell division. During S-phase of the cell cycle,
the centrosome replicates to form two centrosome organelles that separate at mitosis and form
each of the two microtubule organizing centers (MTOC) for bipolar division [181].
Supernumerary centrosomes have been shown to cause aneuploidy and are used as an indirect
measure of the rate of CIN in cancer lines [158]. The presence of more than two centrosomes can
lead to multipolar mitosis, which can induce chromosomal missegregation errors during cell
division. However, the post-mitotic viability of multipolar cell division is likely low but in rare
cases can drive clonal aneuploidy [167, 182]. Recently, it was reported that centrosomal
amplification is characteristic to hPSCs and that increased passage number puts downward
pressure for centrosome errors [175].

We sought to characterize centrosome behavior in hPSC across: (a) cell lines of different
origin, (b) over passage number, (c) during initial enzymatic induced single- cell dissociation,
and (d) aneuploidy vs euploidy. ICC was used to stain pericentrin for centrosome visualization
and -tubulin for microtubules of the spindle-assembly apparatus. First, we investigated the
baseline supernumerary centrosome profile of various hPSCs: hEC, H1, H9, BG01, BG01(v),
and hiPSC (Figure 6). The hEC line, 2102Ep, is an established pluripotent carcinoma line from
germ cell tumors with a high degree of karyotypic abnormalities [183]. Thusly, the hECs served
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Figure 6. Human PSC lines exhibit variable expression of supernumerary centrosomes.
BG01s have the highest percent of centrosomes errors. H9s and iPSCs have significantly lower
centrosome errors than either BG01 or H1 line, (*) indicates p< 0.05.
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as a reference line with known CIN. HECs were profiled in triplicate across three continuous
passages, 55, 89, and 104, with an average centrosome error rate of 12.35% (+/- 3.03). For
passages 55, 89, and 104, the supernumerary centrosome error percentages was 15.82% (+/1.76), 11.12% (+/- 1.61), and 10.13% (+/-1.38), respectively. Our results indicate that there is a
certain degree of decreased centrosome errors in the hEC line under prolonged passage. The H1
and BG01 cell line exhibit a high percentage of supernumerary centrosomes. In the H1 cell line
propagated by manual dissection, the supernumerary centrosome percentage was quantitated in
triplicate at three different passages, spanning 70 continuous passages. The percentage of
supernumerary centrosomes at passages 30, 72, and 100 are 10.66 (+/- 1.61), 9.10 (+/- 1.67), and
11.69 (+/- 5.46), respectively, with the average centrosome error across all three manual
passages being 10.48 (+/- 1.3). The increased standard deviation in the H1 cell line at passage
100 is noteworthy, possibly indicating the precipice of centrosome error reduction; however, in
general, we did not observe a decrease in centrosome amplification in the first 100 passages of
the H1 line. Similarly, the BG01 supernumerary centrosome were quantitated in triplicate at two
continuous manual passages, 39 and 64. The percentages of supernumerary centrosomes in
BG01s were found to be 9.48 (+/- 1.26) and 17.65 (+/- 5.50), respectively with a mean of
13.56% (+/- 5.77). The BG01 line at passage 64 was found to contain the highest percentage of
centrosome amplification in our baseline error analysis. Interestingly, among hESC lines, we
found an exception to the high centrosome error rate in the H9 line. On three independently
thawed H9 sublines, at manual passage numbers, 50, 51, and 65- each passage quantitated in
triplicate- we determined an average centrosome error rate of 4% (+/- 2.14). The H9 had
significantly decreased centrosomes errors compared to H1 and BG01 lines, with a p-value less
than 0.05 for each line. We quantitated the centrosome amplification of an iPSC line and found a
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significantly lower percentage of centrosome errors compared to both the BG01 and H1 lines
with p-value < 0.05. The iPSC line at manual passages 11 and 36, each quantitated in triplicate,
exhibited a mean centrosome error rate of 5.01% (+/- 2.16). Therefore, in this analysis we
observed variable expression of supernumerary centrosomes across cell lines and consistent
centrosome errors within cell lines. We did not observe centrosome error reduction within the
first 100 passages.

Since enzymatic dissociation into single cells is positively correlated with an increase in
genomic alterations and centrosome errors are a dominant mechanism causing CIN, we tested
whether passaging hPSCs as single cells would increase the percentage of centrosome anomalies.
Initially, hPSC lines were maintained using manual passaging protocols. The lines were then
switched to enzymatic single-cell dissociation protocols and continuously passaged as singlecells. Since the iPSC and H9 lines had lower centrosome errors, these lines were used for the
centrosome analysis. Interesting, in serial enzymatic culture of the iPSC line, we observed an
accumulation of centrosome errors and a statistically significant increase in centrosome
amplification. Centrosome errors increased from CT-1 to CT-3 to CT-5 and then decreased by
CT-10 and remained similar throughout at passages CT-15, CT-25, and CT-30. The centrosome
error percentage of the hiPSC manually passaged control cells, CT-0, is 5.01 (+/- 2.16). The peak
centrosome error percentage at CT-5 is 18.02 (+/- 2.63), a 3.6 fold increase compared to CT-0
samples. At CT-10, the centrosome percent error decreased to 8.18 (+/- 2.17). CT-5 was
significantly increased relative to CT-0, CT-1, and CT-10 for p< 0.05. Additionally, iPSC CT-1
and CT-3 samples were significantly increased relative to iPSC CT-0 samples, with a p< 0.05.
Continued centrosome analysis on the enzymatically passaged iPSC line showed similar
55

centrosome error percentages for CT-15, CT-25, and CT-30 of approximately 9% (Figure 7). In
the H9 line, compared to manual controls with a percent error of 4% (+/- 2.14), we observed a
statistically significant spike at CT-1 with a percent error of 10.88% (+/- 1.75). Two passages
later at H9 CT-3 the centrosome percent error had already reduced to 4.9% (+/- 0.56) (Figure 8).
Together, the iPSC and H9 data are consistent that transition to enzymatic passaging destabilizes
the mitotic machinery leading to increased centrosomal instability of cell lines propagated as
single-cells.

Next we analyzed differences between karyotypically normal vs abnormal in multiple
(H1, H9, and BG01) hPSC lines. The BG01(v) line demonstrated a striking difference from the
euploid BG01 line. The BG01 line had a centrosome error percentage of 13.56% (+/- 5.77) that
was significantly less in the line of same origin, BG01(v), with a centrosome error percentage of
3.24% (+/- 1.04) (Figure 9). H9 cells with an already low centrosome error rate of 4.0% (+/2.14) had an insignificant reduction at trisomy containing passages 125 and 150 with percentages
of 2.64% (+/- 0.43) and 0.68% (+/- 0.96), respectively. The H1 line had acquired a structural
duplication on chromosome 15p11.2 at passage 97 but displayed no reduction in centrosome
errors by passage 105 with a mean of 15.66% (+/- 1.12). The karyotype analysis does not suggest
that there is an association with genomic selection and centrosome stability. The reduction in the
BG01(v) line could be accounted for by passage number difference between samples.
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Figure 7. Transition to single- cell passaging increases centrosome errors in iPSCs. IPSCs
were maintained by manually passage, CT-0, and then switch to single- cell dissociation (CT).
At CT-0, CT-1, CT-3, CT-5, CT-10, CT-15, CT-25, and CT-30, the percentage of supernumerary
centrosomes were quantitated. Human iPSCs at CT-5 had the highest percentage of centrosome
errors. (*) indicates statistical significance to CT-0, p< 0.05. (**) indicates statistical significance
to CT-0, CT-1, and CT-10, p< 0.05.
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Figure 8. Transition to single- cell passaging increases centrosome errors in H9s. H9s were
maintained by manually passage, CT-0, and then switch to single- cell dissociation (CT). At CT0, CT-1, CT-3, the percentage of supernumerary centrosomes were quantitated. (*) H9s at CT-1
had a statistically significant spike relative to CT-0 and CT-3, p< 0.05.
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Figure 9. Supernumerary centrosome percentages of BG01 vs BG01(v) lines. Euploid early
passage BG01s were compared to the aneuploid BG01(v) line. (*) BG01s have significantly
more centrosome errors than BG01(v)s, p< 0.05.

59

Transcription Correlates With Genomic Copy Number
Culture dominance by variant hPSCs arise from phenotypic selection that likely has a
genotypic association [92]. Therefore, we performed transcriptome analysis to identify
transcriptional patterns and candidate genes conferring selective advantage. Three samples of
abnormal hPSCs were compared to three samples of normal hPSCs in a genome-wide scan using
Affymetrix HGU-133a microarrays. In order to discover biomarkers that might aid the
understanding of genomic instability, differential gene analysis was performed. At a false
discovery rate of 0.05, we found 450 probe sets corresponding to unique genes to be increased
and 393 genes to be decreased. Prior to differential gene analysis, it was known that the BG01(v)
samples contained trisomies on chromosomes 12, 14, 17, and X [82]. We investigated the
existence of a transcriptional expression pattern reflecting these trisomies. It was discovered that
a disproportionate number of significantly increased genes were located in a chromosome
specific manner on chromosomes 12, 14, 17, and X. Specifically, the number of increased genes
per chromosome were determined as 61, 40, 72, and 65, respectively . The normalized ratios of
increased genes on the trisomic chromosomes is significant compared to the distribution of
increased genes on the non-trisomic chromosomes with a p-value of 0.0046 (Figure 10). One
would expect that an extra chromosome would result in a constitutively expressed gene
exhibiting an expression ratio of 3:2 by gene dosage alone. Thusly, on a chromosome specific
basis, we looked at the average expression of all genes present in the normal samples. As
predicted, we see positive fold changes of the mean chromosome expression in present genes
between euploid and aneuploid hPSCs on 12, 17, 14, and X. Notably, chromosomes 17 and X
have mean increases of 1.56 and 1.82, respectively. There is a general tendency for the mean
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Figure 10. Trisomy enrichment of significantly increased genes. In differential gene expression
analysis between normal and abnormal hESCs, 450 genes were found to be increased (black) and
393 decreased (white) between the cell lines. We normalized each chromosome’s count by
dividing by the number of array genes for the respective chromosome. Chromosomes 12, 14, 17,
and X show a marked increase in the normalized ratio of genes that are differentially regulated and
have an increased fold change. For normalized ratio between disomic and trisomic chromosomes,
p-value = .0046.
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expression of present genes on diploid chromosomes in normal hESCs to be negative relative to
the mean expression of the respective chromosome in aneuploid hESCs. Many of the cases are of
negligible value; however, chromosomes 3, 4, 15, and 19 each had their expression in abnormal
hPSCs down-regulated at least 20%, with chromosome 15 exhibiting the highest decrease of
26% (Table 4).

We sought to further determine potential biomarkers. Utilizing four resources for a priori
information, we collected a list of genes for annotation. From the Gene Ontology [184],
biological processes and cellular components were chosen that could be causal in genomic
instability or related to the abnormal hPSC phenotype. These processes included cell cycle, DNA
replication, DNA repair, centrosome, centrosome cycle, centrosome organization, apoptosis, cell
proliferation, cellular response to DNA damage, response to DNA damage. WerbowetskiOgilvie and colleagues demonstrated through functional assays that abnormal hPSCs exhibit
neoplastic progression, including increased self-renewal properties [91]. Therefore, we included
in our list those genes from the PluriNet as a set of potentially biologically relevant genes that
under altered regulation might confer adaptive advantage to abnormal hESCs through increased
self- renewal [177]. Given the increased proliferation of abnormal hESCs that result in outcompeting normal hESCs in culture and the reported similarities in normal and abnormal hESCs
and cancer cells [92, 185], we also added the genes from the Cancer Genome Project [186].
Finally, we included genes reported to be involved in genomic instability [178]. 2031 genes were
included in the analysis. We primarily focused on those genes that had a FDR less than 0.05 and
were located on either chromosome 12, 14, or 17 (Table 5).
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Table 4 Mean Chromosome Specific Transcript Expression of Present Genes
Chromosome
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
Y
X

Normal
229.24
258.9
179.77
173.32
249.16
195.41
196.65
205.6
166.3
229.28
266.95
287.6
176.89
229.57
205.81
236.14
266.14
188.63
233.34
220.23
174.51
174.81
33.83
202.56

Abnormal
223.63
238.87
149.66
144.49
244.07
173.28
181.39
182.65
146.32
215.18
231.15
401.81
174.74
333.79
163.87
224.35
416.29
167.99
188.16
201.3
174.89
166.46
27.57
369.47

Fold
Change
-1.03
-1.08
-1.2
-1.2
-1.02
-1.13
-1.08
-1.13
-1.14
-1.07
-1.15
1.4
-1.01
1.45
-1.26
-1.05
1.56
-1.12
-1.24
-1.09
1
-1.05
-1.23
1.82

# Probe
Sets
1115
728
579
381
499
629
489
389
381
423
553
602
203
374
343
427
602
180
590
298
120
247
14
394

For each chromosome the average of the signal intensities per chromosome for all present genes
was calculated for normal and abnormal samples. The total number of probe sets per chromosome
on the HGU-133A Affymetrix microarray was used to determine chromosome specific average.
The fold change was calculated relative to normal samples, such that a positive fold change value
implies the mean expression is higher in abnormal samples. Chromosomes 17 and X have fold
changes greater than 1.5.
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Table 5 Significantly Increased Genes Located on Trisomy Chromosomes in BG01(v) Line
Symbol
Cytoband
Ontology
Phenotype
KRAS
12p12.1
Ras mediated signal transduction
Cancer
SOCS2
12q
Anti-apoptosis
DYRK2
12q15
DNA damage response, induction of
apoptosis
RFC5
12q24.2-q24.3 DNA repair, DNA replication,
Genomic Instability,
Self-renewal
checkpoint sensor
PSMD9
12q24.31Mitotic cell cycle
q24.32
POLE2
14q21-q22
DNA repair
GPHN
14q23.3
establishment of synaptic specificity at
Cancer
neuromuscular junction
ALKBH1
14q24.3
DNA dealkylation
DYNC1H1 14q32.3-qter
Mitotic spindle organization and
biogenesis
USP22
17p11.2
Positive regulation of mitotic cell cycle
RNMTL1
17p13.3
RNA processing
Self-renewal
PAFAH1B1 17p13.3
Establishment of mitotic spindle
orientation
RPA1
17p13.3
Cancer
DNA repair, checkpoint signaling
predisposition,
Genomic Instability,
Self-renewal
NF1
17q11.2
Positive regulation apoptosis, negative Cancer
regulation of cell proliferation
TIAF1
17q11.2
Anti-apoptosis
PSMD11
17q11.2
Self-renewal
Mitotic cell cycle
COL1A1
17q21.33
extracellular matrix
Cancer
RAD51C
17q22-q23
DNA repair, HR
Genomic Instability
SOX9
17q24.3-q25.1 Apoptosis, Cell proliferation
SEP9
17q25
Cell cycle, GCPR signal transduction
Cancer
EXOC7
17q25.1
Centriolar satellite
ARHGDIA 17q25.3
Anti-apoptosis
Significant genes located on chromosomes 12, 14, or 17 with an FDR less than 0.05. A gene’s
ontology is bold if part of genomic instability [178] or an annotation of interest from Gene
Ontology. Self- renewal genes are from the PluriNet gene set and phenotype cancer from the
Cancer Genome Project. Abbreviations: HR- homologous recombination.
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Candidate Gene Identification for Positive Selection of Trisomy 17
Chromosome 17 is one of the most common genomic abnormalities in hPSCs, occurring
in vitro during hPSC culture and in vivo in hECs [95]. In our research, three hPSC lines
(BG01(v), H9, iPSC) exhibited trisomy 17 during long-term propagation. Additionally,
published reports suggest that 17q25 may be a minimal amplicon for genomically altered hESCs
[92]. Interestingly, 17q25 is reported to be the only species conserved genomic amplification
between homo sapiens and syntenic locus of mus musculus and rhesus macaque [187].
Therefore, we decided to focus specifically on the genes located on this region that were
determined significantly expressed by microarray analysis. Of the three overexpressed genes on
17q25, SEPTIN 9, EXO7, and ARHGDIA, ARHGDIA caught our attention for its established
role in the RHO-ROCK pathway [109, 110, 188]. ROCK inhibitor is used by many labs to
reduce dissociation induced cell death upon loss of e-cadherin based cell-cell contact [45].
ARHGDIA, known as aplysia ras- related homolog guanine dissociated inhibitor- alpha, inhibits
the activation of RHOA by preventing the GDP exchange for GTP [189]. ARHGDIA is an
effector and chaperone for prenylated RHOA [190]. Since RHOA activation is necessary for
ROCK activation, we hypothesized that overexpression of ARHGDIA would reduce activation
of RHOA and therefore lead to increased single- cell survival conferring selective advantage to
hPSCs (Figure 11). Given its genomic location on 17q25, ARHGDIA is of particular interest as a
putative agent in trisomy 17 culture dominance. Notably, we found the protein ARHGDIA to be
highly conserved across vertebrates (Figure 37).
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Figure 11. ARHGDIA inhibition of RHO signaling. Loss of cell-cell contact during single cell
dissociation leads to cell death through activation of Rho signaling. Phosphorylation of myosin
light chain by ROCK induces cytoplasmic membrane blebbing and rupture. ARHGDIA is a
potent inhibitor of RHOA activation. ARHGDIA maintains the inactive RHOA-GDP bound state
by preventing the switch to active RHOA-GTP. We hypothesize that overexpressing ARHGDIA
will reduce RHOA activation, and therefore reduce ROCK associated, pMLC- dependent,
apoptosis leading to increased viability of hPSCs. Abbreviations: pMLC- phosphorylated myosin
light chain, ROCK- rho-associated coil coiled protein kinase.
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Functional Analysis of ARHGDIA in Cell Culture
Having identified ARHGDIA as a candidate gene of interest in trisomy 17 hPSC lines,
we hypothesized that increased expression of ARHGDIA in hPSCs would increase survival
during single cell passaging and confer selective advantage to these populations. Additionally,
with a hypothesized functional role, we further speculated that ARHGDIA could be an
expression marker for trisomy 17. To date, genes located on altered genomic regions having a
functional role in hPSC selective advantage have remained elusive. Since our genomic and
transcriptional data supports an overexpression model, we focused our experimental approach on
increased ARHGDIA expression. To test our selective advantage hypothesis, we established
hPSC lines constitutively overexpressing ARHGDIA using lentivirus transduction approaches.
An affordable and commercially available open reading frame (ORF) for ARHGDIA was
obtained (Thermo Scientific), wherein the ARHGDIA ORF is cloned into their pLOC lentiviral
expression vector. pLOC expression vectors are driven by the human cytomegalovirus (CMV)
promoter and contain a green fluorescent protein (GFP) reporter, tGFP, that is expressed in the
cell’s nucleus and driven by an internal ribosomal entry site (IRES) (Figure 38). GFP expression
is an essential technical feature of our experimental design enabling us to fluorescently identify
cells expressing the ARHGDIA ORF. Via this pLOC based Precision LentiORF expression
system, we stably transduced both H9 and BG01 hPSC lines. For both the H9 and BG01 hPSC
lines, we established ARHGDIA overexpression lines, H9 (Arg) and BG01 (Arg). Similarly, to
generate matched controls, we transduced H9 and BG01 hPSC lines, H9 (GFP) and BG01 (GFP)
with lentivirus to established CMV promoter driven GFP only expressing cells. To enrich for
GFP expressing cells in our transduced lines, all lines were propagated by manual dissection
until time of experiment. Colonies expressing GFP were marked by an objective marker and
67

selected by manual cutting and plating. Serial positive selection on GFP was sufficient for
experiment quality, high percentage, GFP expressing populations. For quality control,
stringently, the percent of GFP expression was checked in each experimental culture. Of
significant technical note, the transduced H9 and BG01 lines exhibited strikingly different
promoter silencing behavior, as determined by GFP signal. The CMV promoter is prone to
silencing in certain hPSCs . GFP silencing in the H9 line was very prominent for both transduced
lines, H9 (Arg) and H9 (GFP), while for both transduced BG01 lines, BG01 (Arg) and BG01
(GFP), the GFP expression was relatively stable.

Arhgdia Overexpression in Transduced and Trisomy 17 containing lines
We first sought to validate overexpression of ARHGDIA in our genetically engineered
lines. Overexpression of ARHGDIA was investigated by quantitative real-time PCR (QPCR),
immunocytochemistry (ICC), and western blot (WB). For QPCR and WB analysis, samples were
compared to matched GFP only and wild-type (WT) controls. For ICC, in the H9 (Arg) line
differences in ARHGDIA signal intensity were compared among GFP positive and GFP negative
reporter gene expressors. By ICC, all cells were positive for ARHGDIA and exhibited diffuse
cytoplasmic localization. Within the H9 (Arg) colony, GFP positive cells had increased
ARHGDIA positive antibody staining in the flourescent red emission channel, relative to GFP
negative cells; thereby, validating that our primary antibody and ARHGDIA expression system
was performing as expected (Figure 12). Next, by QPCR and WB, we compared the H9 and
BG01 hPSC lines: H9 (Arg) relative to the H9 (GFP) and H9 (WT) lines and BG01 (Arg)
relative to the BG01 (GFP) and BG01 (WT) lines. Our QPCR analysis demonstrated that
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Figure 12. ARHGDIA cytoplasmic location and overexpression in transduced hPSC line. H9
stem cell line was transduced with lentivirus co-expressing the gene ARHGDIA (red) and GFP
(green) driven by the CMV promoter. Cells expressing GFP (B), relative to DAPI (blue) only (A),
have increased ARHGDIA protein expression (C, D). ARHGDIA is cytoplasmic localized. Scale
bar= 50 m.
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ARHGDIA was overexpressed in the H9 (Arg) and BG01 (Arg) lines relative to respective GFP
and WT controls. We determined the transcriptional fold change of H9 (Arg) compared to H9
relative to the BG01 (GFP) and BG01 (WT) lines. Our QPCR analysis demonstrated that
ARHGDIA was overexpressed in the H9 (Arg) and BG01 (Arg) lines relative to respective GFP
and WT controls. We determined the transcriptional fold change of H9 (Arg) compared to H9
(GFP) and H9 (WT) to be 5.57 and 5.63, respectively. We determined the transcriptional fold
change of BG01 (Arg) compared to BG01 (GFP) and BG01 (WT) to be 3.83 and 3.05,
respectively (Figure 13). Performing WB analysis, the bands in the lanes for H9 (Arg) and BG01
(Arg) were clearly stronger than the corresponding GFP and WT control lanes. Using
densitometry, we quantitated the signal of each band and determined the fold change of H9 (Arg)
relative to H9 (GFP) and H9 (WT), also likewise for the BG01 (Arg) relative to BG01 (GFP) and
BG01 (WT). In the densitometric analysis, we normalized the values of the target protein signal
intensity against the -tubulin control signal intensity. We calculated the fold change of H9
(Arg) relative to H9 (GFP) and H9 (WT) to be 10.52 and 6.76, respectively. We calculated the
fold change of BG01 (Arg) relative to BG01 (GFP) and BG01 (WT) to be 3.74 and 7.50,
respectively (Figure 14).

By microscopic visualization, GFP expression in the H9 (Arg) line was brighter than GFP
expression in the BG01 (Arg) cells. Additionally, on an absolute scale used in the Accuri C6
flow cytometer, the GFP fluorescence detection values measured on the H9 (Arg) line were
higher than that of the BG01 (Arg); indicating that H9 (Arg) had higher ARHGDIA ORF
expression than BG01 (Arg). This is consistent, with both QPCR and WB data, demonstrating
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Figure 13. ARHGDIA is overexpressed in BG01 (Arg) and H9 (Arg) lines. Using real-time
PCR, the BG01 (Arg) and H9 (Arg) lines overexpress ARHGDIA transcripts relative to their
respective set of controls, BG01 (GFP), BG01 (WT), H9 (GFP), and H9 (WT). For each cell line
n= 3.
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Figure 14. ARHGDIA protein expression in transduced and variant hPSC lines. Western blot
analysis on ARHGDIA protein expression in H9s and BG01s (A). The numbered lanes of the
western blot (A) correspond to the numbered rows in the densitometric analysis (B). The signal
intensities were normalized against maximum -tubulin expression. Fold change values for H9
(Arg) and BG01 (Arg) are relative to H9 (GFP) and BG01 (GFP) and fold change values for H9(v)
and BG01(v) are relative to H9 (WT) and BG01 (WT). -tubulin= 5 kDa and ARHGDIA= 26 kDa.
Abbreviations: Arg- ARHGDIA,  -tub-  -tubulin, WT- wild type, v- genomic variant, GFPgreen fluorescent protein.
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that relative to controls, ARHGDIA fold change was higher in the H9 (Arg) line; and, that total
ARHGDIA expression was greatest in the H9 (Arg) line compared to all other samples. The H9
(Arg) relative to H9 (WT) fold change is similar between QPCR and WB data. Likewise, the
BG01 (Arg) relative to BG01 (GFP) fold change is similar between QPCR and WB data.
However the fold change values between QPCR and WB densitometry is different in magnitude
for H9 (Arg) relative to H9 (GFP) and BG01 (Arg) relative to BG01 (WT) and can be possibly
explained by technical variation in the WB experimentation, since mRNA expression of
ARHGDIA is highly consistent across our euploid controls. Taken together, along with technical
considerations in the densitometric normalization and protein loading variation, the QPCR and
WB data are qualitatively consistent and quantitatively similar for ARHGDIA overexpression in
our transduced lines validating our experimental system.

With a hypothesized functional role, we sought to determine whether increased
ARHGDIA expression may serve as a transcription and protein marker for trisomy 17. To date,
functionally relevant genes conferring selective advantage for trisomy 12, 17, and gain of X have
not been determined. Our microarray data and the literature indicate a strong correlation between
genomic copy number and transcript levels. In a recent study on 104 hPSCs lines, Mayshar and
colleagues demonstrate that gene expression data can predict genomic alterations with ~10Mb
resolution and very high accuracy [89]. Our results are promising but mixed for increased
transcriptional expression of ARHGDIA in trisomy 17 lines. In the trisomy 17 iPSC(v) line, we
observed 3.0 fold increase in ARHGDIA transcription (Figure 15). However, in the trisomy 17
BG01(v) and H9(v) lines, we did not observe increased ARHGDIA expression. Euploid hPSC
samples exhibited consistent quantitative expression of ARHGDIA, similar in manner to a
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Figure 15. ARHGDIA gene expression in trisomy 17 lines. Trisomy 17 hPSC lines carry an
extra genomic copy of ARHGDIA located on 17q25. By gene dosage, we expect to observe at
least a 1.5 fold increase in trisomy 17 lines. In the iPSC(v) line we observe a 3.0 fold change
increase for ARHGDIA. For each cell line n=3.
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housekeeping gene; therefore, observing increased mRNA expression in the iPSC(v) line is
noteworthy. Interestingly, we observed an increase in ARHGDIA expression in the BG01(v) and
H9(v) WB samples, relative to the respective BG01 and H9 euploid samples (Figure 14). Since,
it is notcommon to see relative to the respective BG01 and H9 euploid samples (Figure 14).,
indicating that further experimentation is needed to demonstrate usefulness of ARHGDIA as a
biomarker.
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ARHGDIA Transduced Cell Lines Maintain Pluripotency
In order to confirm that ARHGDIA overexpression did not adversely influence selfrenewal and differentiation, we fully characterized the H9 (Arg) line for pluripotency. For the
BG01 (Arg) line, we conducted QPCR and ICC analyses on transcription factors and cell surface
markers to validate the pluripotent cell state. Similarly, for the H9 (GFP) and BG01 (GFP)
control lines, we conducted QPCR and ICC analyses on transcription factors and cell surface
markers to validate pluripotency.
HPSCs exhibit a typical colony morphology that is more strongly bounded on iMEFs
compared to feeder-free conditions. Cells propagated on Matrigel™ and other feeder-free
conditions are more prone to form hESC fibroblast-like cells (hFs) than those hPSCs propagated
on iMEFs. HFs are single- cells that migrate to the colony periphery forming a niche and are a
sign of differentiation [191]. The iMEF layer density is thought to contribute an opposing force
that increases constraint of the hPSC colony. E-cadherin is expressed in hPSCs and facilitates
cell- cell contact through homotypic bonding to maintain colony morphology [192]. All
transduced lines, ARHGDIA and GFP controls, exhibited standard colony morphology on
iMEFs and Matrigel™. However, the colonies of H9 (Arg) cells manually passaged and
maintained on iMEFs exhibited striking behavior that was significant and consistent compared to
controls. HPSC colonies are often a flat monolayer that penetrate through the iMEF layer, pushes
the iMEFs outward, and forms a raised ridge at the hPSC and iMEF contiguous boundary, with
the hPSCs being concave to the iMEFs. In contrast, the H9 (Arg) colonies were highly mounded,
very dense, and convex to the iMEF layer (Figure 16). The random white-edge cobblestone
morphology was significantly present and bright within the H9 (Arg) colony. The BG01 (Arg)
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colonies did not exhibit a difference in monolayer cell formation from control lines BG01 (GFP)
and BG01 (WT). Thus, overexpression of ARHGDIA was associated with cell line specific
morphological alterations that were present in H9 (Arg) but not BG01 (Arg) cells.

Differentiating hPSCs lose expression of the AP activity; therefore, AP staining is a
quick, reliable, and sensitive method to screen for hPSCs in culture [14]. The H9 (Arg) lines
were AP positive at greater than 20 passages post- transduction (data not shown). Similarly, the
H9 (GFP) lines were AP positive at greater than 10 passages, post- transduction (data not
shown). While AP staining has been reported to be a sensitive marker, more specific pluripotent
markers for cell-surface and transcription factors are routinely used to stringently validate
pluripotency. The transcription factors OCT4, SOX2, and NANOG are essential to pluripotency
and highly specific cell surface markers have been identified, such as SSEA4. Down regulation
of hPSC markers during initial stages of differentiation is poorly understood; however our long
term propagation of H9 (Arg) and BG01 (Arg) cultures indicate stable maintenance of
pluripotency. At greater than 30 passages, post-transduction, the H9 (Arg) lines exhibited
positive protein expression for OCT4 and SSEA4 by ICC. Similarly for the BG01 (Arg) lines, at
greater than 30 passages, post- transduction, positive protein expression for OCT4 and SSEA4
was observed by ICC (Figure 17 and Figure 18). Using QPCR analysis, we quantitatively
assessed gene expression for the pluripotent transcription factors OCT4 and NANOG. For H9
(Arg), QPCR was performed at greater than 25 passages, post-transduction. At each passage, the
H9 (Arg) was transcriptionally positive for OCT4 and NANOG. Prior to RNA isolation, for each
sample, we performed a quality control check on H9 (Arg) expression purity. By flow cytometry,
we validated the percentage of cells in the H9 (Arg) sample overexpressing ARHGDIA by
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Figure 16. H9 (Arg) colonies exhibits increased cell- cell contact and mounded morphology.
Each line exhibits standard pluripotent stem cell colony formation. H9 (Arg) (A-C) has marked
increased multi- cell layer morphology as demonstrated by the increased density in phase contrast
image (A) and fluorescent image (B) and overlay (C). H9 (GFP) (D-F) exhibits standard monolayer
colony morphology concave to surrounding iMEF layer. BG01 (Arg) (G-I) exhibits standard
monolayer colony morphology concave to surrounding iMEF layer. Scale bar= 100m.
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performed a quality control check on H9 (Arg) expression purity. By flow cytometry, we
validated the percentage of cells in the H9 (Arg) sample overexpressing ARHGDIA by
measuring the percentage of cells that were GFP- positive. Similarly, the BG01 (Arg) line at
greater than 10 passages, post-transduction, was positive for OCT4 and NANOG mRNA. The
H9 (GFP) and BG01 (GFP) lines positively expressed OCT4 and NANOG transcripts. When
comparing H9 (Arg) and BG01 (Arg) lines for OCT4 and NANOG against human dermal
fibroblasts, there were fold changes of one order of magnitude for OCT4 and 2 orders of
magnitude for NANOG. Across hPSC lines, the fold changes patterns against the fibroblasts
were similar (Figure 19). Within hPSC lines, the relative expression of OCT4 and NANOG for
transduced lines is consistent with self- renewal. H9 (Arg) line exhibited an increase in fold
change for OCT4 relative to H9 (WT) and H9 (GFP). In the other lines, there was a slight but
acceptable decrease in OCT4 and NANOG expression relative to H9 (WT) and BG01 (WT)
samples (Figure 20), decrease that may be attributed to culture time. The wild type samples were
often freshly thawed cultures, where the transduced lines were subjected to long- term
continuous passaging. The OCT4 and NANOG expression of H9 (Arg) and BG01 (Arg) relative
to GFP, WT, and hDF controls confirms self- renewal of these lines.

Pluripotency is defined by self-renewal and differentiation potential into ectoderm,
endoderm, and mesoderm. Having validated self-renewal, we sought to determine whether the
H9 (Arg) line could differentiate into each of the three embryonic germ layers. We used the
hanging drop method for EB formation, in which cells were dissociated as single cells, plated at
5000 cells per drop, and subsequently cultured in suspension in non- adherent agar plates.
Interestingly, EB formation from single-cells was aided by the use of 10 M ROCKi. Initial
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attempts without ROCKi did not form cell aggregates. H9 (Arg) with ROCKi formed tight
aggregates that were fixed at 20 days and subsequently sectioned and analyzed by histopathology
for germ layer specific expression. We observed presence of all three primitive germ layers,
indicating that the cells retained their differentiation capabilities (Figure 21). Taken together, this
data suggest that ARHGDIA overexpression does not influence self-renewal and the stem cells
remain pluripotent with tri-lineage potential.
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Figure 17. H9 (Arg) and BG01 (Arg) cells self- renew and express OCT4. Positive nuclear
expression of the OCT4 transcription factor in H9 (Arg) lines (A-C) and BG01 (Arg) lines (D-F).
H9 (Arg) and BG01 (Arg) lines were propagated greater than 20 and 10 passages, respectively.
DAPI- blue (A, D), OCT4- red (B, E), and DAPI/OCT4 nucleus overlay (C, F). Scale bar= 50 m.
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Figure 18. H9 (Arg) and BG01 (Arg) cells self- renew and express SSEA4. Positive expression
of the cell surface marker, SSEA4, in H9-arg+ lines (A-C) and BG01-arg+ lines (D-F). The H9
(Arg) and BG01 (Arg) lines were propagated greater than 20 and 10 passages, respectively. DAPIblue (A, D), SSEA4- red (B, E), and DAPI/SSEA4 overlay (C, F). Scale bar= 50 m.
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Figure 19. H9 (Arg) and BG01 (Arg) lines exhibit high expression of pluripotent
transcription factors relative to human dermal fibroblasts. The experimental and control lines
for H9s and BG01s were validated for pluripotent marker expression relative to human dermal
fibroblast. The fold change values are determined via the CT method using GAPDH as the
reference gene. Abbreviations: Arg- ARHGDIA, GFP- green flourescent protein, WT- wild type.
For each cell line n=3.
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Figure 20. H9 (Arg) and BG01 (Arg) express pluripotent transcription factors. The
experimental (Arg) and control lines (GFP) for H9s and BG01s were validated for pluripotent
marker expression against WT lines. The fold change values are determined via the CT method
using GAPDH as the reference gene. Fold change was calculated relative to hDFs. Abbreviations:
Arg- ARHGDIA, GFP- green flourescent protein, WT- wild type. For each cell line n=3.
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Figure 21. Histopathological evidence of germ- layer specification in embryoid bodies
generated from H9 (Arg) lines. Hematoxylin and eosin-stained histologic sections of EBs from
H9 (Arg) lines. The tri-lineage differentiation is indicative of pluripotency. Magnification is 20x.
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ARHGDIA Confers Selective Advantage and Increases Clonality
For the H9 (Arg) line, we used two assays to test our hypothesis that ARHGDIA
overexpression will improve hPSCs cultured as single-cells. The first, a competition based assay,
consisted of co-cultures of cells overexpressing ARHGDIA vs. non-overexpressing cells. The
second assay tested clonality of single- cells seeded at low density. Prior to the selection
experiments and clonality assay, the H9 (Arg) lines were maintained by manual passage. Using
an objective marker for identification, GFP- positive colonies were manually cut by fire- pulled
Pasteur pipette and plated as small clumps. This provided a natural opportunity for co-cultures of
H9 (Arg) that were GFP- positive and H9 (Arg) that were GFP- negative, H9 (Arg(+)) and H9
(Arg(-)), respectively. In this co-culture experimental design, all cells had been treated similarly,
including lentiviral exposure and equivalent passage number. The only difference between the
GFP- positive vs. GFP- negative subpopulations is differential ARHGDIA expression as
validated by prior ICC, QPCR, and WB analysis. To determine the influence ARHGDIA
overexpression has on selective advantage, competition co-culture experiments were performed
on two independent H9 (Arg) sublines from the same transduction, H9 (Arg) s.1 and H9 (Arg)
s.3. For each subline, the competition- based assay was initiated as a mixture of H9 (Arg(+)) and
H9 (Arg(-)) co-cultures, discriminated by GFP reported expression, that were switched from
manual passaging to enzymatic passaging. Co-cultures were continuously passaged on iMEFs,
subjected to 40 m filtering, and plated as single-cells.
At each passage, the percentage of GFP- positive cells was measured by flow cytometry with
controls in place for autoflourescence and gating for live cells only. Both H9 (Arg) s.1 and H9
(Arg) s.3 sublines exhibited strong competitive advantage when passaged as single-cells. For the
H9 (Arg) s.1 co-culture, there was a total of 53.2% H9 (Arg (+)) cells for the initial enzymatic
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harvest prior to plating, CT-0. For the H9 (Arg) s.3 co-culture, there was a total of 42.0% H9
(Arg (+)) cells for the initial enzymatic harvest prior to plating, CT-0. After serial, single-cell
passaging, the total H9 (Arg(+)) percentages for the H9 (Arg) s.1 and H9 (Arg) s.3 lines reached
90.6% and 93.5%, respectively (Figure 22 and Figure 23). The distribution of H9 (Arg (+)) cells
is bimodal and thusly can be divided into H9 (Arg (high)) and H9 (Arg(low)), as measured by
the strength of GFP signal intensity. For each subline, H9 (Arg) s.1 and H9 (Arg) s.3, the H9
(Arg(high)) increased relative to the H9 (Arg(low)), suggesting that magnitude of ARHGDIA
expression positively correlated with increased selective advantage. For the H9 (Arg) s.1 subline,
the initial percentage of H9 (Arg (high)) was 27.8%, equaling 52.3% of the total H9 (Arg(+))
cells. At the final passage, the percentage of H9 (Arg (high)) in the total population was 83.7%,
equaling 92.4% of the total H9 (Arg(+)) cells. For the H9 (Arg) s.3 subline, the initial percentage
of H9 (Arg (high)) was 17.9%, equaling 43.8% of the total H9 (Arg(+)) cells. At the final
passage, the percentage of H9 (Arg(high)) in the total population was 89.0%, equaling 95.2% of
the total H9 (Arg(+)) cells. Of note, in both sublines, there was an initial delay of competitive
advantage, where the percentage of total H9 (Arg(+)) remained similar. For the H9 (Arg) s.1,
dominant competitive advantage occurred between CT-4 to CT-6, in three passages. For the H9
(Arg) s.3, competitive advantage occurred between CT-4 to CT-6, in three passages. For the H9
(Arg) s.3, competitive advantage of total H9 (Arg(+)) occurred between CT-8 to CT-13, in six
passages. Noteworthy, in the H9 (Arg) s.3 subline, within a short span between passages CT-8 to
CT-10, the H9 (Arg(high)) nearly tripled from 24.4% to 72% of the total population.

Next, we determined whether H9 (Arg) cells exhibited increased clonality. First, we only
used H9 (Arg) cultures that had a high percentage (>80%) of H9 (Arg(+)) cells, as measured by
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Figure 22. H9 (Arg) s.1 demonstrates competitive advantage under single- cell passaging.
H9 (Arg) lines was maintained on iMEFs under manual passage (CT-0) then switched to singlecell dissociation (CT-1 to CT-6). By flow cytometry, the percentage of GFP positive cells was
measured at each passage to assess the proportion of cells overexpressing ARHGDIA. The
distribution of GFP signal intensity is bimodal with GFP- high and GFP- low fractions. The H9
(Arg) GFP- high exhibits increased competitive advantage relative to H9 (Arg) GFP- low.
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Figure 23. H9 (Arg) s.3 demonstrates competitive advantage under single- cell passaging.
H9 (Arg) lines was maintained on iMEFs under manual passage (CT-0) then switched to singlecell dissociation (CT-1 to CT-13). By flow cytometry, the percentage of GFP positive cells was
measured at each passage to assess the proportion of cells overexpressing ARHGDIA. The
distribution of GFP signal intensity is bimodal with GFP- high and GFP- low fractions. The H9
(Arg) GFP- high exhibits increased competitive advantage relative to H9 (Arg) GFP- low.
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GFP- positive expression using flow cytometry. Both sublines, H9 (Arg) s.1 and H9 (Arg) s.3,
were used in four independent seedings. Three of the four seedings were plated in triplicate for a
total of 10 samples points. The H9 (GFP) controls were plated in triplicate at three different
passages for a total of 9 samples and the H9 (WT) was plated in triplicate or duplicate at 3
different passages for a total of 8 samples. H9 (Arg), H9 (GFP), and H9 (WT) were manually
passaged until clonal analysis. Clonality was tested on the first enzymatic passage (CT) to
control for selective pressure. Each replicate was 40 m filtered and seeded on iMEFs at 1000
cells per 35 mm petri dish to ensure low density single-cell plating. On day 7, colonies were AP
stained to aid visualization and validate pluripotency.

The increased clonality of the H9 (Arg) cells relative to H9 (WT) and H9 (GFP) was striking and
statistically significant. Statistical analysis was carried out in the most stringent and conservative
manner. Each passage number seeding was considered a biological replicate and the set of plates
at that passage seeding were considered technical replicates. The average of the technical
replicates was taken for a single biological replicate mean. In this manner, the biological
replicate means were used for statistical analysis and hypothesis testing. The number of
biological replicates used were H9 (Arg) [n=4], H9 (GFP) [n=3], and H9 (WT) [n=3]
respectively. The observed average number of colonies for H9 (Arg), H9 (GFP), and H9 (WT)
are 125.66, 31.44, and 42.83, respectively (Figure 24). Therefore, the clonality of H9 (Arg) cells
has an increased fold change of 4.0 and 2.93 relative to H9 (GFP) and H9 (WT), respectively.
Furthermore, the number of H9 (Arg) colonies was statistically significant to both H9 (WT) and
H9 (GFP) with p-values, 0.0023 and 0.0004, respectively. The results from both of the
competition and clonality experiments support the conclusion that H9 (Arg) cells have
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Figure 24. ARHGDIA overexpression increases clonality. H9 control and experimental lines
were continually propagated by manual dissection prior to clonal survival analysis. Under initial
enzymatic dissociation and 40 m filtering 1000 single cells were plated per 35mm petri dish.
Colonies were AP- stained and counted on Day 7. H9 (Arg) line overexpressing ARHGDIA has
significantly increased number of colonies in low density single-cell seeding. * indicates
significance (p < 0.01) for H9 (Arg) compared to H9 (WT) and H9 (GFP). Abbreviations: ARGARHGDIA, WT- wild type, GFP- green fluorescent protein.
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competitive advantage by increasing clonality. We did not observe strong promoter silencing in
the BG01 (Arg) manually passaged lines, as in the H9 (Arg) manually passaged lines; therefore,
we speculated a technical improvement to the co-culture experimental design.

We repeated our competition based assay with BG01 (Arg) cells, while making a few
refinements to the approach. First, we controlled for the percentage of the initial BG01 (Arg)
seeding population and changed the co-culture to BG01 (Arg) vs BG01 (WT). Similarly, we
changed our experimental control to co-culture of BG01 (GFP) vs BG01 (WT). In our BG01
(Arg) vs BG01 (WT) competition assay, we varied substrates, seeding density, and ROCKi
exposure. As in the H9 (Arg) competition experiments, we maintained our BG01 (Arg), BG01
(GFP), and BG01 (WT) by manual passaging until time of co-culture experiments, upon which
cells were switched to enzymatic passaging. A 40 m filter was used for plating as single-cells.
Percent BG01 (Arg) populations were quantitated by flow cytometry on GFP- positive
expression.

The results on competitive advantage of BG01 (Arg) cells in mixed co-cultures with
BG01 (WT) are striking. BG01 (Arg) lines exhibited immediate and dominant competitive
advantage when co-cultured with BG01 (WT). The co-culture of BG01 (GFP) with BG01 (WT)
did not exhibit competitive advantage. The initial co-culture seeding percentage for BG01 (Arg)
and BG01 (WT) was estimated to be 30 % for BG01 (Arg) and 70 % for BG01 (WT). The actual
initial seeding percentage of BG01 (Arg) varied slightly from this estimate, as 30% was factored
by the percentage of BG01 (Arg(+)) cells in the BG01 (Arg) line. The initial seeding percentage
for the co-cultures involving BG01 (Arg)- 25k, BG01 (Arg)- 50k, and BG01 (Arg)- ROCKi is
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26.97%. For BG01 (Arg)- 100k and BG01 (Arg)- iMEFs, the initial BG01 (Arg) percentages are
18.29 and 25.17%, respectively. Each co-culture experimental condition was carried out in
parallel biological triplicates. In their feeder- free cultures, Rosler and colleagues report trisomy
20 as the most frequently observed aberration [193], while Trisomy 17 is prominent in our hPSC
cultures propagated on iMEFs. Thus, we wanted to determine whether iMEFs or Matrigel™
influenced competitive advantage of BG01 (Arg) vs BG01 (WT) co-cultures. Both substrates
showed strong selection for BG01 (Arg) cells in the mixed populations with BG01 (WT). By
enzymatic passage, CT-3, the BG01 (Arg) co-culture, seeded at 100k on iMEFs, had increased to
82.87% of the mixed population. Comparatively, the BG01 (Arg) co-culture, seeded at 100k on
Matrigel™, had increased to 79.11% of the mixed population, by enzymatic passage, CT-5. For
both enzymatic passages, CT-2 and CT-3, the percent BG01 (Arg) is significantly higher in the
iMEFs cultures compared to Matrigel™, p <0.01. These results suggest that iMEFs positively
influenced BG01 (Arg) competitive advantage compared to Matrigel™ (Figure 25A).

Next, we wanted to determine whether seeding density influenced competitive advantage.
BG01 (Arg) and BG01 (WT) co-cultures were plated on Matrigel™ at seeding densities of 25k,
50k, and 100k cells. Since, low single-cell seeding density could adversely influence survival in
WT cells by reduced paracrine signaling [149] or increased cell migration distance [64, 194], it is
possible that relative competitive advantage would be greater in low density BG01 (Arg) cocultures compared to high density BG01 (Arg) co-cultures. BG01 (Arg) competitive advantage
was clearly demonstrated within 5 enzymatic passages for each seeding density. The maximal
BG01 (Arg) percentages for 25k, 50k, and 100k, are 91.19, 89.52, and 79.11%, respectively,
with percentage of BG01 (Arg) cells greatest in the samples seeded at 25k (Figure 25B). The
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higher percent of BG01 (Arg) in the 25k samples relative to 50k is significant for CT-4 (p< 0.05)
and is significant relative to 100k for CT-4 and CT-5 (p < 0.05).

Finally, we decided to test the importance of ROCKi given its role in increasing singlecell viability during plating. We hypothesized that ROCKi would reduce the selective advantage
of BG01 (Arg) cells relative to BG01 (WT) by increasing the survival of dissociated BG01 (WT)
cells. BG01 (Arg) and BG01 (WT) co-cultures were seeded at 100k on Matrigel™ in the
presence of ROCKi, Y27632 in the growth medium. Strikingly, when 10M ROCKi was added
during plating and withdrawn on day 2 at medium exchange, we did not observe competitive
advantage of BG01 (Arg) cells (Figure 25C). Starting with an initial BG01 (Arg) percentage of
26.97%, by CT-5 the mean percentage of BG01 (Arg) cells was only 29.02%. These results are
in stark contrast to the other BG01 (Arg) experiments, without the use of ROCKi, in which
competitive advantage was demonstrative. We checked whether BG01 (GFP) subpopulations
displayed competitive advantage. Indeed this was not the case; moreover, modest GFP silencing
was evident, albeit not to the extent observed with H9s (Figure 25D). BG01 (GFP) vs BG01
(WT) co-cultures started at an estimated 29.7% BG01 (GFP) that by CT-5 had decreased to
15.06% BG01 (GFP). Combined across BG01 (Arg) and H9 (Arg) co-culture and clonality
experiments, our results presents compelling evidence that ARHGDIA overexpression confers
selective advantage to hPSCs through increased single- cell survival, and this selective advantage
can be ameliorated by the addition of ROCKi. This is suggestive that when passaging as singlecell cultures, conditions that increase single- cell survival of genomically normal cells could
reduce the selective pressure for clonal genomic variants.
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Figure 25. BG01 (Arg) hESCs demonstrate competitive advantage across substrates and
seeding densities and selection is inhibited by ROCKi, Y27632. BG01 (Arg) lines co- cultured
with BG01 (WT) have competitive advantage across substrates (A) and seeding densities in
35mm petri- dishes (B). ROCKi, ameliorated this seeding density (C) and BG01 (GFP) control
did not exhibit competitive advantage (D).
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DISCUSSION AND CONCLUSIONS

Trisomy 17 is the most common clonal abnormality observed in our hPSCs lines and was
scored in the H9, BG01v, and iPSC lines. In two independent lines, trisomy 17 was common to
both trisomy 12 and a gain on X, H9 and iPSC, respectively. Trisomy 17 could increase the
presence of additional genomic alterations and further promote genomic instability. Interestingly,
trisomy 17 has not been as commonly reported in the literature for iPSCs as in hESCs [89];
however it dominated the iPSC culture relatively early in our enzymatically passaged cultures at
CT-31. The structural gain of 15p11.2 in the H1 line has not been reported elsewhere, except for
a trisomy 15 [88].Thus, our findings of an amplicon on chromosome 15 may be used to minimize
the region of candidate genes on chromosome 15 for further analysis. It is interesting to consider
whether trisomy 17 or trisomy 20 is the more dominant variant; since, two recent large- scale
studies have focused on the 20q11.21 amplicon [87, 88]. Since trisomy 20 was not previously
reported in the BG01(v) line and trisomy 17 was observed first [82], then this could represent an
emerging dominant genomic species, alternatively the trisomy 20 cells were only 34% of culture
and at that passage had not exhibited the same culture dominance that as trisomy 17 cells
comprising 92% of the population. The recurrent abnormality, trisomy 12, was observed in the
BG01(v) and H9 lines. NANOG is located on chromosome 12 and increased NANOG
expression may confer self- renewal benefit to these populations. Trisomies 12 and 17 are
hallmarks of germ cell tumors and the presence of these alterations in hPSCs poses significant
clinical concern [95, 195, 196].
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Our observations are consistent with the literature that genomic amplifications have a
much greater propensity to be clonal than genomic losses which are infrequently observed as
populations [88]. Interestingly, when using single- cell based approaches, such as G-banding and
FISH, for non- clonal random alterations, monosomies are observed at least or greater than
trisomies [103, 106, 148] and chromosomes 17 and 20 are 2 of the 3 least observed aneuploidies
in PGS embryos [146].

While initial reports suggested that 20q11.21 amplification was preferential for feederfree cell culture [193]; after an accumulation of studies, no clear correlation exists between
particular recurrent abnormalities and culture conditions or protocols [88]. However, it has been
reported that enzymatic passage increases genomic instability more than two-fold [87]. Our
results show that trisomy 17 is disproportionately expressed under routine use of iMEFs and CT
passaging, indicating the possibility that under single- cell passaging a gain on chromosome 17 is
associated with a clonal phenotype. In our studies, we carefully recorded the parental history of
the lines and reduced the culture parameters. Loring and colleagues have pointed out the
importance of carefully tracking the history and pedigree of PSC lines in the experimental design
of hPSC genomic instability studies, in order to tease out potential cell culture condition specific
recurrent abnormalities. Thus, our approach may have aided the consistency of observing
trisomy 17 under the single- cell passaging protocol [88].

To date, a profile of different hPSC lines characterizing their degree of genomic
instability has not been reported; however examples of lines with increased CIN has been
suggested [195]. Such a profile could help researchers determine preferential lines and optimal
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conditions. However, it remains ambiguous whether mutational load can be decreased, since a
high degree of CIN maybe characteristic of the pluripotent state. Our non- clonal g- band
analysis on BG01(v) and H9 cell lines suggest that the BG01(v) has greater genomic instability
than the H9 line. However, without further analysis, it is not clear whether this increased
genomic instability is due to cell line specificity, passage number, or an acquisition of a mutator
phenotype from cultured-induced aneuploidy. The BG01(v) line at CT-23 exhibited a complex
genomic phenotype with trisomy 12, 17, and X. In the non-clonal analysis of the H9 line, at CT26 passage, only 5.7% of cells exhibited a random aberration. This is an appreciably lower
percentage than the ~30% estimated frequencies for non- clonal aberrations in hPSCs [103, 106].
None of the H9 CT-26 cells expressed more than one genomic abnormality. Therefore, the
emergence of trisomy 17 in the H9 line is not associated with a concomitant increase in random
alterations and the time to karyotypic abnormality was similar for both H9 and BG01(v) lines.
Together this is suggestive that different cell lines may exhibit varying degrees of genomic
instability and that selection mechanisms may be the dominate force in the emergence of
genomic variants.

Consistent with a prior report [175], we found that the H1 and BG01 lines have an
inherently high centrosome error rate. Holubcova and colleagues report centrosome
amplification percentages ranging from 12-24% in 12 independent hPSC lines, while not
reporting specific percentages for the commonly used H9 cell line. In two of the cell lines (H9
and iPSC) we studied, high centrosome error rates were not observed, suggesting that not all
hPSCs suffer from high centrosomal amplification. However, it is worth noting that both the H9
and iPSC lines became abnormal in about the same enzymatic passage span as the BG01 line and
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the H1 line took nearly 100 passages to gain a small duplication. The significance of centrosome
errors is unclear; however it is interesting to consider the post- mitotic survival of cells with
supernumerary centrosome. Post- mitotic survival of cells with supernumerary centrosomes
could increase upon extended passaging and may help explain the observation in our BG01(v)
line that had a low centrosome error rate but a high rate of random genomic aberrations and
clonal species.

Enzymatic passages increases the presence of genomic abnormalities. As one means to
explain this observation among labs, we investigated whether enzymatic passage increases
mitotic instability. Both the H9 and iPSC lines demonstrated increased centrosomal instability
when switched from manual to single- cell passaging. Ding and colleagues have reported that
single- cell dissociation in primed PSCs results in E-cadherin instability [45]. WNT signaling
members, GSK3 and - catenin, are essential in pluripotent cells for fidelity in chromatin
segregation and the centrosome duplication, respectively [197, 198]. These are attractive
candidates for elucidating the mechanism driving single- cell dissociation induced centrosome
errors.

Recurrent variations in hPSCs line are well established and highly suggestive of strong
selective forces in establishing a variant population. Consistent with Mayshar and colleagues
report on gene expression data to predict genomic copy number, our chromosome- specific mean
expression levels of active genes demonstrated a dosage correlation with genomic copy number.
[89]. Thus, our transcriptional data is highly consistent with the view that a 1.5 fold increase in
gene expression is better tolerated by the cellular system than a 50% reduction [146].
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Significantly increased genes located on recurrent amplifications are strong candidates for a
biological role in positive selection. In our transcriptional analysis, ARHGDIA was the most
attractive candidate gene for its location, gene expression, and established role as an inhibitor of
RHO signaling and downstream effector ROCK [110].

Our study is the first to functionally demonstrate a gene located on chromosome 17 that
confers selective advantage to hPSCs when passaged as single- cells. Analysis on pluripotency,
suggests that ARHGDIA overexpression does not adversely affect self- renewal or
differentiation, as ARHGDIA transduced cultures were maintained for several months and
differentiated into EBs exhibiting all three germ layers. Two independent approaches for
ARHGDIA’s influence on clonal survival were tested in H9 cell lines. The H9 (Arg(+)) cells
demonstrated competitive advantage against H9 (Arg(-)) cells; however on independent runs
there was an initial delay in the competitive advantage. Likely this is due to CMV promoter
silencing that puts downward pressure on the assay; however an alternate hypothesis is the
existence of a epigenetic or post- translation modification that coupled with ARHGDIA
overexpression confers selective advantage to a subpopulation of H9 (Arg(+)) cells. Another
possibility for this could be a genomic alteration in the H9 (Arg(+)) subpopulation in each of the
co- cultures. However, independent runs suggests a companion genomic alteration is unlikely.
The H9 clonality assay, did not suffer from the technical issue of promoter silencing, since the
cells were GFP- positive at seeding. Indeed single- cell survival was drastically increased in H9
(Arg) cells compared to controls suggesting clonality as the phenotypic advantage.
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Our BG01 (Arg) lines exhibited increased stability of ARHGDIA ORF expression. The
BG01 (Arg) cells quickly dominated co-cultures in as quickly as three passages in the iMEF
sample. Across seeding densities on Matrigel™, the BG01 (Arg) cells with the lowest seeding
density of 2.5k/cm^2, exhibited the fastest culture dominance. Human PSCs are known to
migrate promoting pro-survival cell- cell contact [194] and for trophic paracrine signaling that
may also increase cell- viability [149, 199]. Either of these factors may have reduced the survival
of the BG01 (WT) at lower seeding densities with a relative increase in selective advantage of
the BG01 (Arg) cells. This poses interesting questions regarding the mechanism in which
ARHGDIA overexpression improves single- cell survival, through the possibilities of inhibiting
ROCK- associated blebbing, facilitating migration, or in an unidentified cell adhesion manner
affecting clonal survival.

Ben- David and colleagues suggest that ROCKi may reduce the rate of genomic
adaptation of hPSCs in culture by reducing selective pressure [200]. However, to date there has
not been any data to support this hypothesis. Our experiments are the first to provide compelling
evidence that ROCK inhibitors can be used to reduce the selection of competitive subpopulations. Current approaches to study selection of genomic variants are plagued by the nature
of the biological phenomena in question with culture time to genomic alterations highly variable
and easily take months to observe. Therefore culture adaptation studies are wrought with
experimental design and statistical issues, when seeking to assess the influence of culture
conditions and components. While we do not prove a tight causation for ARHGDIA expression
and trisomy 17 selection, these results strongly encourage future studies to eludicate
ARHGDIA’s role in hPSC culture. Recently, BCL- XL has been shown to mediate the selective
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advantage of the 20q11.21 amplicon. Together, ARHGDIA and BCL-XL provide strong
candidate genes for engineering genetically defined and biologically relevant hPSC lines that can
be used to study culture conditions influencing positive selection of genomic variants. Such
genetically defined lines can be used to test small molecules, substrates, 3 dimensional culture
systems, and the primed vs naïve pluripotent state on an amenable experimental time- scale.
With the widespread culture dominance of trisomy 17, development of the hPSC (Arg) model is
a significant advance in the field empowering culture based approaches to reducing the rate of
culture adaptation of hPSC genomic variants.
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CHAPTER 3

Characterizing Self- Renewal and Differentiation in Human Pluripotent Stem Cells Propagated
in Naïve State Culture Conditions
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ABSTRACT

Optimized culture conditions that reduce genomic instability during scale-up remains a
significant challenge for industry and clinical applications. Traditionally, hPSCs have been
cultured in a “primed” pluripotent state in bFGF- supplemented growth medium. In contrast,
mouse embryonic stem cells are cultured as “naïve” pluripotent stem cells in LIF- dependent
conditions. Here we report the culture of H9 and BG01 lines in growth medium devoid of bFGF
and in medium containing LIF plus two inhibitors, MEK inhibitor PD0325901 and p38 inhibitor
SB203580. These LIF + 2i lines were manually and enzymatically passaged, as well as cultured
on inactivated mouse embryonic fibroblasts and Matrigel™ with iMEF conditioned media. LIF +
2i cultures supported self- renewal for more than a year, irrespective of passage method or
substrate. In the BG01 line, after 18 manual passages, self- renewal was aided by switching to
single- cell passaging. Histopathological analysis of embryoid bodies generated from the H9
(LIF) lines demonstrate tri-lineage differentiation along each germ- layer. Real- time qPCR
analysis supports EB histological analysis confirming expression of germ- layer specific genes;
however, the H9 (LIF) s.4 subline cultured on Matrigel™ was the only line to show increased
mRNA expression of each germ layer. Finally, to ascertain the influence of LIF + 2i conditions
on genomic instability, the percentage of supernumerary centrosomes was quantitated on H9
(LIF) lines maintained on iMEFs and Matrigel™. We observed a statistical increase in
supernumerary centrosomes of H9 (LIF) propagated on Matrigel™. Together, our results
indicate that hESCs can be stably maintained in LIF-based growth medium while retaining trilineage differentiation potential; and that, substrates should be considered when determining the
optimal culture conditions for reducing mutation pressure.
104

INTRODUCTION

Recent advances have contributed to our molecular understanding of mammalian
pluripotency, the self-renewal network, and culture conditions that influence pluripotencyassociated genomic and epigenetic adaptations. Early work on embryonic stem cells
demonstrated conserved and divergent pathways between mESCs and hESCs [18]. While
initially perceived to be species- specific differences, recent findings have increased a speciesconserved perspective of mammalian pluripotency by identifying distinct metastable stem cell
states within the pluripotent compartment [29, 35]. Through the successful derivation of mouse
lines from the pre- implantation and post-implantation epiblast [39], representations of “naïve”
and “primed” pluripotency have been established [24]. The most distinctive culture associated
feature is that naïve pluripotent stem cell lines are LIF- dependent, whereas primed pluripotent
stem cell states rely on bFGF for self- renewal [32]. The emerging model is that hPSCs reside in
a primed PSC state that is similar to the post- implantation mouse epiblast stem cells (mEpiSCs)
[19]. Both naïve and primed pluripotent stem cells express the three essential pluripotencyassociated transcription factors, OCT4, SOX2, and NANOG; however, NANOG may have an
important role in naïve pluripotency and establishing the ground state of pluripotency [26].
In the well- established conditions for mPSC culture, there are clear technical and biological
benefits compared to hPSC cultures. Establishing naïve culture conditions for hPSCs has
significant implications for basic research and industry applications for regenerative medicine. In
2008, rodent pluripotent stem cell culture was generalized in conditions that established the
ground- state of pluripotency. In this ground- state pluripotency, LIF could be removed and
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inhibitors to MEK and GSK3 were sufficient to maintain self- renewal, even in recalcitrant mice
strains and rat lines [31, 69, 70]. While there is progress in establishing naïve hPSC lines, culture
conditions supporting the ground state of human pluripotency remains an important but
significant challenge [20, 37]. Heterogeneity in stem cell culture has plagued the standardization
of directed differentiation protocols, with different hPSC lines showing lineage-bias [49].
Additionally, hPSC cultures have been plagued by poor survival at passage, particularly as
single-cells during plating [45]. Furthermore, genome- editing approaches in mPSCs are not
amenable in hPSCs. Culturing hPSCs in a similar naïve pluripotent states as mPSCs maintains
significant advantage for the field by potentially: (a) reducing phenotypic heterogeneity in stem
cell culture, (b) increasing viability of clonal stem cells and yields during scale-up, (c)
standardizing directed differentiation protocols by reducing lineage- bias and increasing uniform
control of aggregate size from single- cell seeding, (d) genetically manipulating clonal cells, and
(e) enabling homologous recombination in hPSCs [30, 31, 113]. Developing hPSC culture
conditions that promote the ground state of pluripotency may also minimize the components
needed for defined culture conditions.

During development, the pluripotent state is transient; whereas, during hPSC culture,
pluripotency is forced indefinitely during long-term propagation [27]. Consequently, cell culture
introduces significant environmental stressors to hPSCs during propagation inducing continual
adaptation of the pluripotent stem cell population. In the presence of LIF, mouse embryonic stem
cells are amenable to single- cell passage on gelatin coated petri-dishes [58]. High selective
pressure on hPSCs for clonal survival has been suggested to drive the appearance of common
chromosomal abnormalities [82, 84]. Indeed, the enzymatic dissociation of hPSCs into single106

cells during passaging increases genomic instability and the appearance of genomic alterations
by more than two-fold [87].

In this study, we cultured 4 independent sublines comprised of two different parental
hPSC lines, H9 and BG01, for more than one year in LIF + 2i conditions. Along with the
cytokine LIF, two inhibitors MEK inhibitor PD0325901 and p38 inhibitor SB203580 were used
as part of medium formulations. The MEKi, PD0325901, has been used in mPSC culture to
establish the ground state [23]. Human PSCs lines were cultured on iMEFs and Matrigel™ and
passaged manually and as single- cells. LIF + 2i cultures supported self- renewal, irrespective of
passage method or substrate. In the BG01 line, after 18 manual passages, self- renewal was aided
by switching to single- cell passaging. Indefinite self- renewal is shown using standard stem cell
characterization assays and pluripotency is demonstrated in vitro using EBs for differentiation
into each of the three germ layers. EBs from the H9 (LIF) line maintained on Matrigel™
exhibited a consistent increase in germ- layer specific mRNA. Histopathological analysis
supported the presence of all germ- layers in each of the EB samples; however the use of ROCKi
during the hanging drop step increased EB yield and differentiation.

Work from our laboratory and others has identified supernumerary centrosomes as
prominent and variable to culture conditions [175]. Indirect measures on genomic instability,
such as centrosome error analysis, have the distinct benefit of being able to assess culture stress
at each passage prior to selection bias of genomic variants. After establishing LIF + 2i based
culture conditions support self- renewal, we tested two different substrates, iMEFs and
Matrigel™, to determine their influence on centrosomal instability. We found H9 (LIF)
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propagated on Matrigel™ had an increased percentage of supernumerary centrosomes compared
to H9 propagated on iMEFs. Since centrosome amplification is known to cause CIN [167], there
is potential for concern when considering its use in LIF-based conditions. Our results show that
hESCs can be stably maintained for long-term propagation in LIF-based medium while retaining
tri-lineage differentiation potential; and that, substrates should be considered when determining
the optimal culture conditions for reducing mutation pressure.
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METHODS

Human Pluripotent Stem Cell Culture
HPSCs were maintained on mitomycin C–inactivated mouse embryonic feeder (MEF)
layers in DMEM/F-12, 20% knockout serum replacement, 2 mM L-glutamine, 1% nonessential
amino acids, 50 U/mL penicillin, 50 microgram per mL streptomycin (all from
Gibco/Invitrogen), 0.1 mM beta mercaptoethanol (Sigma), and 4 ng/mL bFGF (Sigma). Cells
were enzymatically passaged via sequential dissociation using 1mg/ml type IV collagenase
(Gibco) and 0.05% trypsin–ethylene-diamine tetra-acetic acid (trypsin-EDTA, Invitrogen) or
manually passaged by fire-pulled pasteur pipette. hPSCs were replated on fresh feeder layers or
Matrigel™. Cells grown in Matrigel™ were coated at the lot specific recommended dilution in
35mm plates. Medium was conditioned on iMEFS at 5 x 106 cells per T-75 flask for 24 hours up
to day 10 from seeding. For growing hPSCs in naive-like conditions, LIF + 2i medium, BG01
and WA09 were cultured in hPSC growth media supplemented with 1-μM mitogen-activated
protein kinase/extracellular signal-regulated kinase kinase (MEK) inhibitor PD0325901 (Sigma)
and 5-μM p38 (Sigma) inhibitor SB202190 and 1×103 human LIF (Invitrogen).

In vitro differentiation of hPSCs and histopathology of hPSC-derived embryoid bodies.
To generate embryoid bodies (EBs), hPSCs were dissociated using 0.05% trypsin and
resuspended in growth medium without bFGF. EB formation was facilitated using suspension
culture by a hanging drop method, where cells at a density of 5,000 cells per 20 microliters drops
were suspended from a Petri dish lid in 50-100 droplets with the addition of 10 micro-molarity
ROCKi. After 3 days, the surviving EBs were transferred onto agar plates at in 20 mls of EB
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(hPSC, -bfgf) media to facilitate further differentiation with media changes every 2 days for a
total differentiation duration of 15-20 days. EBs were prepared for morphological analysis by
fixation in 4.0% PFA in 1.5 mL microfuge tubes at 50-100 EBs per tube. EBs were rinsed with
PBS to remove PFA, resuspended in 200 lL melted 4% low melting point agarose (Sigma
Aldrich) at 42 degrees C, and incubated for 2 h to allow settling. Final pelleting and agarose
solidification were performed with brief room temperature centrifugation at 500g. Agarose
embedded samples were removed as single plugs and processed by dehydration with increasing
ethanol concentration to 100% followed by xylene and paraffination in a Leica TP1020 tissue
processor. Hematoxylin and Eosin (H and E) staining was performed on microscope slide
mounted 5 lm sections in a Leica Autostainer XL workstation (Leica Microsystems, Richmond,
IL). Images were acquired using an Olympus BX51 microscope (Olympus, Center Valley, PA)
using the default imaging parameters.

Antibodies and Immunocytochemical Analysis
HPSCs cultured on Matrigel™ or iMEFs in four chambered glass slides or cover slips in
35mm dishes were fixed via paraformaldehyde (PFA, 4%) in PBS or 80% Methanol.
Permeabilization for intracellular markers was achieved with 0.2% Triton X-100 in PBS. 3%
normal goat serum was used for blocking and to dilute antibodies. Fixed cells were incubated
with primary antibodies: OCT4 (Santa Cruz Biotechnology, Santa Cruz, CA), SSEA4 (Millipore,
Temecula, CA), Pericentrin (Abcam), Beta-tubulin (Developmental Studies Hybridoma Bank),
ARHGDIA (Santa Cruz Biotechnology, Inc.). Goat anti-mouse IgG, anti- rabbit conjugated to
Alexa 488 or Alexa 594 (Molecular Probes, Eugene, OR) were used as secondary antibodies.
Centrosomes were visualized with percentrin and the spindle apparatus by -tubulin. Cells were
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counterstained with DAPI (4'-6-diamidino-2-phenylindole). At 40x magnification, centrosomes
were counted per mitotic cell and the polarity recorded. Fluorescent images were acquired using
a Cool- Snap EZ camera (Photometrics, Tucson, AZ) mounted on a Nikon Eclipse TE 2000-S
inverted microscope (Nikon, Melville, NY) with NIS Elements BR software.

RNA isolation, real time reverse transcription quantitative polymerase chain reaction and
gene expression analysis
RNA was isolated from hPSCs propagated at various passages under different conditions
and from EBs after 15 days in suspension using DNA/RNA All Prep (Qiagen) and quantified
using BioMate3 UV-VIS Spectrophotometer (Thermo Scientific, Waltham, MA) or Nanodrop
2000. cDNA was synthesized from 1 mg of RNA using cDNA High Capacity reverse
transcription kit (Applied Biosystems, Foster City, CA). Transcriptional expression on genes
listed in Table 6 were analyzed using quantitative real time RT-PCR (QPCR). QPCR was
performed on a Bio-Rad CFX96 Touch Real-Time PCR Detection System. Comparative gene
expression analysis (three replicates) was conducted using the CT or CT method depending
on the analysis and samples. GAPDH was used for normalization in all analyses. Relative gene
expression for hPSC experimental samples was assessed against hPSC controls and reported as
fold change and the student’s T- test used for statistical significance testing.

Alkaline Phosphatase Assay
Staining for alkaline phosphatase was performed as per manufacturer instructions (Vector
Laboratories, Burlingame, CA). Briefly, the hPSCs were rinsed in with deionized water to
remove traces of growth medium. The final solution was prepared by adding in order 2 drops of
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each constituent to 200mM Tris HCl buffer, pH 8.5. The hPSCs were incubated in the final
mixture for 45 min in the dark and images were acquired using a Nikon DS-Fi1 camera mounted
on a Nikon TS100 Microscope (Nikon, Melville, NY).
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RESULTS

hESCs cultured in LIF + 2i proliferate and maintain stem cell colony morphology
After long- term propagation in LIF + 2i containing hESC medium, we performed the
standard pluripotent stem cell characterization assays widely accepted to demonstrate the hPSC
state. We cultured two independent parental lines, H9 (LIF) and BG01 (LIF), for greater than 30
passages. Three independent sublines lines of H9 (LIF) were passaged in parallel, H9 (LIF) s.2,
H9 (LIF) s.3, and H9 (LIF) s.4. The H9 (LIF) s.2 and H9 (LIF) s.3 were maintained on iMEFs
and the H9 (LIF) s.4 was propagated on Matrigel™. Prior to switching to LIF + 2i conditions,
the H9 and BG01 lines were maintained by manual passaging on iMEFs. For the H9 (LIF) lines,
the cultures were concomitantly switched to LIF + 2i conditions and passaged by enzymatic
single- cell dissociation methodologies. The H9 (LIF) sublines were initially seeded at high
density at 20-25k/cm2. In contrast to hESCs maintained in bFGF containing medium, the H9
(LIF) sublines on initial enzymatic passage, CT-1, had high viability and formed robust colonies
with strong boundaries and cobblestone morphology (data not shown). For the next few
passages, viability of the iMEF sublines decreased and the H9 (LIF) s.1 subline was discarded
due to poor viability. After this initial cytokine adaptation, the H9 (LIF) s.2 and H9 (LIF) s.3
proliferated very well and was continuously propagated for over a year. Interestingly, two
morphologically distinct colony types emerged, one type was compact and mounded and the
other was flatter and spread out (Figure 26B). On Matrigel™, the viability of H9 (LIF) s.4
remained consistently high but heterogeneity in colony formation increased between, p4 and p6,
as a significant number of single cells peripheral to the colony emerged. Often these single cells
are considered signs of differentiation and these single cells were similar to the human
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pluripotent stem cell derived fibroblasts (hPDFs) reported by Bhatias’s group [191]. However,
the presence of robust stem cell colonies was very prominent during these passages. Starting on
p7 of H9 (LIF) s.4 on Matrigel™ culture, the seeding density was reduced to 7.5k/cm2. The
cultures responded very well with little signs of differentiation; and, in general, the cultures were
homogenous for robust colonies with strong boundaries and cobblestone morphology (Figure
26C).

The BG01 (LIF) line was manually propagated on iMEFs for the first 18 LIF + 2i
passages and then was switched to enzymatic single- cell passaging and maintained on iMEFs.
By morphological analysis, manual passaging of BG01 (LIF) demonstrated a high degree of
differentiation Figure 39A. For the initial five LIF + 2i passages, greater than 50% of colonies
differentiated; however, manual selection of morphologically superior colonies supported
continued propagation. Significant differentiation in the BG01 (LIF) manually passaged cultures
persisted until greater than 15 passages Figure 39B. At passage 18, the plates were switched to
enzymatic passaging. During the initial enzymatic passaging the cells had good viability, formed
robust colonies with strong borders and cobblestone morphology. The colonies were mostly
monolayer at BG01 (LIF), p20 and CT-2. Around BG01 (LIF), p23 and CT-5, the emergence of
compact and mounded colonies became more prominent. By morphological analysis, the BG01
(LIF) handled single-cell passaging better than manual passaging. Morphologically, both the H9
(LIF) and BG01 (LIF) handled the initial enzymatic transition well with good viability and
strong colony formation.
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It is widely recognized that differentiating hPSCs lose expression of the alkaline
phosphatase (AP) marker. We found the AP stain to be a sensitive method to screen for
undifferentiated hPSCs in LIF + 2i conditions. In the H9 (LIF) s.2, H9 (LIF) s.3, and H9 (LIF)
s.4 lines the colonies were AP-positive for greater than or equal to 30 passages in LIF + 2i
medium. Similarly, the BG01 (LIF) line was AP positive at passage 30 in LIF + 2i medium
(Figure 26, D-E).

hPSCs propagated in LIF + 2i medium are able to self-renew and maintain
undifferentiated state
Empirical data increasingly supports a complex model of pluripotency consisting of
heterogeneous metastable states, with the transcription factors OCT4, SOX2, and NANOG
common to both naïve and primed mammalian pluripotency. Using immunocytochemical
analysis, we assessed pluripotency in the H9 (LIF) and BG01 (LIF) lines, at multiple passages
extending greater than or equal to 30 passages in LIF + 2i conditions. At each passage assessed,
the sublines of the H9 (LIF) and BG01 (LIF) lines were OCT4 and SSEA4 positive (Figure 27
and 28). In the hPSC sublines (H9 (LIF) s.2 and H9 (LIF) s.3) propagated on iMEFs, we noticed
that the single- cells peripheral to the colony maintained OCT4 expression, while in compact
colonies, cells in the mounded center lost OCT4 expression. In the BG01 (LIF) line, p17,
manually maintained on iMEFs, differential OCT4 expression was observed Figure 40. Thus,
OCT4 appears to be a sensitive marker for hPSC cultures in LIF + 2i conditions. Using real- time
PCR, we quantitatively assessed pluripotent stem cell gene expression on the transcription
factors OCT4 and NANOG. Transcriptional activation of OCT4 is a key factor for inducing
pluripotency from differentiated cells and its expression is essential to hPSC self-renewal.
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Figure 26. LIF based medium supports strong colony formation and alkaline phosphatase
positive staining of hESCs on iMEFs and Matrigel™. Each line is positive for strong colony
borders, cobblestone morphology, high nuclear to cytoplasmic ratio, and AP staining. BG01 (LIF)
cultured on iMEFs (A, D). H9 (LIF) cultured on iMEFs (B, E). H9 (LIF) cultured on Matrigel™
with conditioned medium (C, F). Each line propagated for greater than 30 passages. Scale bars=
100m.

116

Figure 27. Positive OCT4 expression in hPSCs propagated in LIF+2i containing medium.
Positive nuclear expression of the OCT4 transcription factor in lines BG01 (LIF) on iMEFs (AC), H9 (LIF) on iMEFs (D-F), and H9 (LIF) on Matrigel™ (G-I). Each of the hPSC lines were
propagated greater than 30 passages. DAPI- blue (A, D, G), OCT4- green (B, E, H), and
DAPI/OCT4 nucleus overlay (C, F, I). Scale bar= 50 m.
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Figure 28. Positive SSEA4 expression in hPSCs propagated in LIF+2i containing medium.
Positive cell- surface expression of the SSEA4 in lines BG01 (LIF) on iMEFs (A-C), H9 (LIF) on
iMEFs (D-F), and H9 (LIF) on Matrigel™ (G-I). Each of the hPSC lines were propagated greater
than 30 passages. DAPI- blue (A, D, G), OCT4- green (B, E, H), and DAPI/OCT4 nucleus overlay
(C, F, I). Scale bar= 50 m.
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NANOG is a pluripotent specific marker that is critical in formation of epiblast from the ICM
and is biallelically expressed in the ground- state [22]. To determine the maintenance of the selfrenewal program, we compared H9 (LIF) sublines and BG01 (LIF) to H9 and BG01 lines
cultured in bFGF medium and also to human dermal fibroblast (hDFs). H9 (LIF) RNA was
isolated from samples that were cultured for greater than 20 passages and the BG01 (LIF) RNA
samples, more than 30 passages.

Each of the H9 (LIF) and BG01 (LIF) lines were transcriptionally positive for OCT4 and
NANOG. The fold change of NANOG in the hPSC (LIF + 2i) lines relative to hDFs ranged
between 3k-5k fold increase. For OCT4, the samples grown on iMEFs, H9 (LIF) s.2, H9 (LIF)
s.3, and BG01 (LIF) the fold change relative to hDFs ranged between 23-26 fold increase. The
H9 (LIF) s.4 grown on Matrigel™ had a 6.1 fold change for OCT4 relative to hDFs (Figure 29
and Figure 30). For iMEF cultures, the hPSC (LIF + 2i) samples were greater than or equal to the
respective hPSC (bFGF) samples for OCT4 and NANOG expression. Relative to the hPSC
(bFGF) samples, OCT4 fold change increases for H9 (LIF) s.2, H9 (LIF) s.3, and BG01 (LIF)
are 2.7, 2.9, and 1.8, respectively. Likewise, relative to the hPSC (bFGF) samples, NANOG fold
change increases for H9 (LIF) s.2, H9 (LIF) s.3, and BG01 (LIF) are 1.0, 1.5, and 1.4,
respectively. The H9 (LIF) s.4 line was positive for OCT4 and NANOG expression; however,
OCT4 and NANOG expression decreased to 72% and 91% in the H9 (LIF) s.4 line relative to H9
(bFGF) samples (Figure 31 and Figure 32).
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Figure 29: H9 (LIF) samples maintain high OCT4 and NANOG expression relative to
human dermal fibroblasts. Three independent sublines of H9s were cultured in LIF + 2i
containing medium: H9 (LIF) s.2 (A), H9 (LIF) s.3 (B), and H9 (LIF) s.4 (C). The fold change
values are determined via the CT method using GAPDH as the reference gene. Fold change
was calculated relative to hDFs. A, B, C have drastically increased NANOG expression relative
to hDFs and significantly increased OCT4 expression relative to hDFs.
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Figure 30: BG01 (LIF) samples maintain high OCT4 and NANOG expression relative to
human dermal fibroblasts. BG01 (LIF) and BG01 (bFGF) were compared to hDFs. The fold
change values are determined via the CT method using GAPDH as the reference gene. Fold
change was calculated relative to hDFs. Both BG01 (LIF) and BG01 (bFGF) have similar
increased OCT4 and NANOG expression relative to hDFs. BG01 (LIF) and BG01 (WT) were
evaluated in triplicate, n=3, and the resultant geometric mean for each was used for determining
the fold change.
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Figure 31: H9 (LIF) expresses OCT4 and NANOG at higher levels than H9 (bFGF). Three
independent sublines of H9s were cultured in LIF + 2i containing medium: H9 (LIF) s.2 (A), H9
(LIF) s.3 (B), and H9 (LIF) s.4 (C). Fold change values are determined via the CT method
using GAPDH as the reference gene. A and B have increased OCT4 expression relative to H9s
propagated in bFGF containing hESC media. H9 (LIF) s.4 has comparable expression of OCT4
and NANOG as H9s propagated in bFGF containing hESC medium.
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Figure 32: BG01 (LIF) expresses OCT4 and NANOG at higher levels than BG01 (bFGF).
BG01 (LIF) was compared to BG01 samples propagated in bFGF containing hESC medium. The
fold change values are determined via the CT method using GAPDH as the reference gene.
BG01 (LIF) has increased OCT4 and NANOG expression relative to BG01s propagated in bFGF
containing hESC medium. BG01 (LIF) and BG01 (WT) were evaluated in triplicate samples,
n=3, and the resultant geometric mean for each line was used for determining the fold change.
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hESC cultured in LIF + 2i conditions maintain in vitro differentiation capabilities.
Pluripotency is defined by self-renewal and the capacity to differentiate into each of the
three germ layers, ectoderm, endoderm, and mesoderm. Having validated self-renewal, we
sought to determine whether each of the three H9 (LIF) sublines propagated for at least 20
passages would demonstrate tri-lineage differentiation. EBs were formed via the hanging drop
method from single- cells seeded at 5000 cells per drop. Interestingly, EB formation was aided
by exposure to 10M ROCK inhibitor (ROCKi) during the initial hanging drop step. On the H9
(LIF) s.4 subline maintained on Matrigel™, two consecutive attempts to form EBs without
ROCKi exposure were unsuccessful in generating EBs. In the presence of ROCKi, more than
twice the number of EB aggregates formed on the sublines, H9 (LIF) s.2 and H9 (LIF) s.3,
compared to the same sublines without ROCKi exposure. A noticeable difference in EB
morphology was observed between samples grown on iMEFs vs Matrigel™. EBs from H9 (LIF)
s.4 were dense tight aggregates, with increased size-uniformity and spherical symmetry.
However, the H9 (LIF) s.2 and H9 (LIF) s.3 EBs had cystic pockets, were lobular and nonuniform in size Figure 41.

For histopathological analysis, we analyzed 5 independent EB samples across two serial
passages. Each samples consisted of 30-100 EB aggregates. The first sample set consisted only
of H9 (LIF) s.2 and H9 (LIF) s.3 without ROCKi treatment. The subsequent sample set consisted
of H9 (LIF) s.2, H9 (LIF) s.3, and H9 (LIF) s.4 exposed to ROCKi during the initial hanging
drop step. All samples demonstrated differentiation and most of the samples exhibited each of
the three germ layers. Endoderm was the least expressed germ layer and this could be attributed
to insufficient duration in suspension culture of only 15 days. ROCKi exposure seems to have
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influenced differentiation, as both samples without ROCKi treatment were less differentiated
than the three samples with ROCKi treatment. ROCKi (-) samples exhibited the presence of
neural rosettes, primitive connective mesenchyme, and cyst- like structures suggestive of
endoderm. ROCKi (+) samples exhibited neural ectoderm, primitive mesenchyme, some muscle,
and lined vascular formation indicative of endoderm (Figure 33).

Next we performed real- time qPCR analysis on the EBs that were generated from each
of the three H9 (LIF) sublines. For analysis, we paired the expression data of OCT4 and
NANOG between the H9 (LIF) sublines and their corresponding EB sample, EB s.2, EB s.3, EB
s.4. Indeed, we observed significant down regulation of OCT4 and NANOG in each of the EBs
samples, relative to their H9 (LIF) counterpart. The OCT4 fold change decrease is -205.3, -76.6,
-10.3 for EB s.2, EB s.3, and EB s.4, respectively. The NANOG fold change decrease is -18.6, 6.2, and -6.2 for EB s.2, EB s.3, and EB s.4, respectively (Figure 34). Down- regulation of these
pluripotency specific transcription factors suggests that our H9 (LIF) cultures maintained
indefinite self- renewal, and upon prolonged propagation retained the capacity to differentiate.
Figure 35 presents the results of our germ layer marker gene expression in our EB samples. Our
germ- layer panel of 6 genes consisted of Nestin and SOX1 for ectoderm, IGF2 and brachyury
(T) for mesoderm, and AFP and GATA-4 for endoderm. A difference was observed in the
mRNA profile between the EBs generated from iMEF maintained cultures and the Matrigel™
maintained line. The fold change expression pattern in the iMEF maintained samples is
consistent. Independently, EB s.2 and EB s.3 samples show up- regulation and down- regulation
of the same germ- layer associated genes. In the EB s.2 and EB s.3 samples, AFP was drastically
increased and GATA-4 was marginally increased. In the EB s.4 sample, 5 of the 6
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Figure 33. Histopathological evidence of germ- layer specification in embryoid bodies
generated from hPSCs propagated in LIF + 2i conditions. Hematoxylin and eosin-stained
histologic sections of EBs from H9s propagated in LIF + 2i containing hESC medium. Neural
rosettes indicate primitive ectoderm (left). Primitive mesenchyma is present with connective
tissue like structures (middle). Vascular and interior- lining like structures are observed that are
suggestive of primitive endoderm (right). Magnification is 40x.

126

Fold Change

10

1

0.1

0.01

0.001

Oct-4

Nanog
E

F

G

Figure 34: Embryoid bodies lose OCT4 and NANOG expression. Embryoid bodies were
generated from each of the H9 (LIF) sublines. EB expression of OCT4 and NANOG relative to
H9 (LIF) samples were markedly decreased. Fold change values are determined via the Livak
CT method using GAPDH as the reference gene. Abbreviations: E- EB s.2 relative to H9
(LIF) s.2, F- EB s.3 relative to H9 (LIF) s.3, G- EB s.4 relative to H9 (LIF) s.4.
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Figure 35: Embryoid bodies express germ- layer specific markers. Embryoid bodies were
generated from each of the H9 (LIF) sublines. EB s.4 has an increase in 5 of 6 germ- layer
associated genes. The EB s.2 and EB s.3 samples show a demonstrative increase in AFP
expression and a marginal increase in GATA-4 expression. Fold change values are determined
via the Livak CT method using GAPDH as the reference gene. Abbreviations: E- EB s.2
relative to H9 (LIF) s.2, F- EB s.3 relative to H9 (LIF) s.3, G- EB s.4 relative to H9 (LIF) s.4.
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germ- layer genes demonstrated an increase in expression. IGF2 was at the limits of positive
detection with a CT value of 38.32. Therefore, IGF2 could be viewed as absent in both H9 (LIF)
s.4 and EB s.4 samples. The expression of endodermal lineage marker AFP is remarkable. In all
three EB cultures, AFP transcript levels is strikingly increased. Taken together, this data suggest
LIF + 2i conditions support pluripotency and that hPSC (LIF) lines self- renew indefinitely and
maintain tri-lineage differentiation capacity.

Human PSCs grown in LIF + 2i culture exhibit substrate dependent centrosome stability
Compared to genotyping, indirect measures on genomic instability, such as centrosome
error analysis, have the distinct benefit of being able to assess culture stress at each passage prior
to selection bias of genomic variants. In contrast, techniques such as karyotyping can require
months before a genomic aberration can be detected. Prior data from our lab and others has
identified the prominence of supernumerary centrosomes in hESC culture suggesting that
centrosomes should be monitored when testing new culture conditions [175]. We initially
established that the H9 line, propagated in bFGF conditions, has a relatively low centrosome
error rate of approximately 4%. Therefore, the H9 line was chosen for the centrosome error
analysis on LIF + 2i conditions between iMEFs and Matrigel™. The H9 (LIF) s.2 and H9 (LIF)
s.3 sublines maintained on iMEFs were compared to the H9 (LIF) s.4 line propagated on BD
Matrigel™. Each subline was assessed in triplicate across two passages. The H9 (LIF) s.4
subline had been in LIF + 2i containing media for 15 and 25 passages and the total passage count
was passages 65 and 75. The H9 (LIF) sublines maintained on iMEFs had an average centrosome
error rate of 3.51% (+/- 1.17). However the H9 (LIF) s.4 line maintained on BD Matrigel™ has
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an average percentage centrosome errors of 10.76% (+/- 1.84), with the centrosome error
increase found to be statistically significant (p< 0.01) (Figure 36).
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Figure 36. Increased supernumerary centrosomes in H9 (LIF) propagated on Matrigel™.
H9 (LIF) samples maintained on BD Matrigel™ demonstrate a significantly increased number of
supernumerary centrosomes compared to lines maintained on iMEFs. (*) indicates p-value <
0.01.
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DISCUSSION AND CONCLUSIONS

In this study, we were able to demonstrate the long- term self- renewal of hPSCs in a low
complexity LIF + 2i medium, devoid of bFGF. Use of MEKi is notable, since it has been used to
culture ground state naïve mPSCs. This LIF + 2i formulation contained p38i, instead of GSK3,
as suggested by Xu and colleagues, and merited further characterization of self- renewal and
differentiation in these LIF-response hPSC cukture conditions [112]. The hPSC (LIF) cultures
were maintained for greater than 30 passages and were positive for all markers associated with
self- renewal. Notably in our hPSC (LIF) lines, maintained on iMEFs, OCT4 and NANOG had
increased expression relative to hPSC (bFGF) samples. In hPSCs, NANOG is a target of SMAD
2/3 induced by bFGF, therefore the sustained and high expression of NANOG in our lines in the
absence of bFGF is strongly supportive of a distinct self- renewal program supported by LIF +
2i. The presence of LIF- responsive hPSC is highly indicative that a ground state for hPSCs
exists [24, 25]. It will be interesting to explore the distribution of NANOG positive- cells in
order to determine if the LIF+2i culture condition increases homogeneity of NANOG- high
expressors and influences the allelic expression of NANOG, as has been reported for the ground
state of mPSCs [22, 26].

LIF + 2i medium formulations supported survival and proliferation of hPSCs. The initial
single- cell passaging in LIF conditions was more robust than in bFGF conditions, which is
consistent with prior reports that culture converted naïve hPSCs have increased clonal yields
[20]. However, in subsequent transitory passages, yields decreased and then cultures were stably
and robustly maintained. This is possibly due to significant differentiation of the H9 cells upon
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LIF + 2i exposure, where a subpopulation of convertible hPSCs were able to emerge and be
established as stable robust self- renewing LIF+ 2i dependent hPSCs. Since these cells are likely
clonal, then these converted cells are more likely to pass on the LIF+2i responsive phenotype to
their progeny. In contrast to the single- cell culture, differentiation was persistent in the BG01
(LIF) manually passaged lines. However, upon transition to enzymatic dissociation, BG01 (LIF)
culture homogeneity significantly improved, minimal morphological differentiation was
observed, and the BG01 LIF + 2i gained stable robust gene expression. The benefit of single- cell
dissociation for LIF + 2i hPSCs is unclear at this time. However, in single- cell culture the
selection process is on clonal cells, a phenotype more suited for naïve pluripotency. Additionally,
since E-cadherin is turned over during single- cell dissociation and E-cadherin and WNT
signaling are tightly coupled, single- cell dissociation may perturb GSK3 and - catenin
signaling. Given that GSK3i is used to establish the ground state of mPSCs, then there exists the
possibility of pro- survival WNT signaling upon dissociation of hPSCs (LIF + 2i) passaged as
single- cells. Histopathological analysis of EBs confirmed the expression of each of the three
germ layers. However it is noticeable that the addition of ROCKi improved EB yields and
increased the level of differentiation. Additionally, EBs generated from hPSCs propagated on
MatrigelTM were denser and more symmetrical, thus in generating EBs, BD Matrigel™ seems
preferable to iMEFs.

Although the real time PCR analysis yielded mixed results across different genes,
consistent patterns existed indicating that the results contain information of biological relevance.
Perhaps the dominant factor in lack of robust differentiation in the short EB culture time of 15
days could be a factor, given that EBs are often cultured for 20 days or more. Another
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consideration is to choose a better primer selection for genes more indicative of the naïve
pluripotent state. AFP is an extraembryonic endoderm marker expressed in the cells supporting
the epiblast cells and is typically not robustly in differentiated hPSCs that should have definitive
endoderm. In our studies, we observed strong up-regulation of AFP and since AFP is a marker of
early development at the pre-implantation stage, this is promising and suggests the need to
screen additional genes for their expression in EBs obtained from hPSCs propagated in LIF + 2i
conditions. Another interpretation of the EB QPCR data is that the hPSCs propagated under LIF
+2i conditions maintained robust stem cell self- renewal but had difficulty in readily
differentiating in the timeframe provided. A similar result was observed by Buecker and
colleagues, where their HLR5 hPSC (LIF) line maintained self- renewal but lost differentiation
capacity [30].

Notably, the LIF + 2i conditions that were used in this study did not utilize the same
inhibitors published for the murine ground state culture conditions [29]. Instead of using
GSK3i, we used p38i as recommended by Xu and colleagues. Recently, Ware and colleagues
demonstrated that naive hPSC lines can be derived in LIF + 2i conditions (GSK3-) and suggest
using a reverse toggling with HDAC inhibitors first, followed by FGF+ 2i. However, in our LIF
+ 2i (p38i) cocktail this “toggling” did not seem necessary. Hanna and colleagues, recently
published the use of 2i/LIF, p38i, JNKi together with FGF2 and TGF-Beta1 to culture human
iPSCs in a converted naïve pluripotent state [20]. Their group’s similar use of p38i is notable;
however, their formulation is complex and strikingly combines the use of LIF and bFGF.
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In conclusion, the LIF + 2i medium used in this study is a simple formulation that was
found to be successful in maintaining self- renewing hPSCs. Gene expression analysis indicate
that the EBs from the H9 (LIF) s.4 line were differentiating with an observable upregulation in
five of the six genes, indicating tri-lineage differentiation potential. Studies on use of this culture
condition for ascertaining core difference between hPSCs in their naïve and primed state is now
feasible.
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CHAPTER 4

Conclusions and Future Directions
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Numerous studies have shown that RHO signaling pathway has a critical role for PSCs in
survival and essential roles in cellular proliferation, differentiation, and migration [109, 194,
201]. Data from our laboratory is consistent with the requirement of RHO signaling for
maintenance of cell-cell contact in cohesive hPSC colonies through ROCK and pMLC activation
of myosin II [188]. We have observed that small molecule inhibition of ROCK, by Y27632,
demonstrates reversible inhibition of cell-cell contact by F-actin staining, (Figure 42), that does
not appear to adversely influence self- renewal. ROCKi inhibitors are routinely used by labs for
the culture of hPSCs to increase survival, particularly during single- cell plating. However, the
consequences of ROCKi exposure in hPSC culture is unknown, and undesirable side- affects are
suspected, such as an increase in genomically abnormal hPSCs; as, ROCKi may have antiapoptotic side- effects that would allow the persistence of variant hPSCs, since apoptosis in
hPSCs is an integral mechanism in preserving genetic integrity [153, 202]. Additionally, RHOROCK signaling has essential roles in mitosis during centrosome separation and cytokinesis
[203-205]. Thus, concerns for routine use of ROCKi in hPSC cultures seems warranted.
Therefore, alternative approaches to using ROCKi for increasing the viability of hPSCs during
propagation and scale- up is a significant and unmet challenge in the field.

Recently, the molecular pathway responsible for the pluripotent state dependency of
dissociation-induced apoptosis was elucidated [76]. Ohgushi and colleagues demonstrate that
RHO signaling activation upon loss of e-cadherin based cell-cell contact is different between
naïve and primed PSCs. Upon loss of e-cadherin-dependent intercellular contact, primed PSCs
are characterized by a high amount of active RHOA and low amount of active RAC1. Thus,
primed PSCs activate ROCK induced blebbing and cell death upon dissociation. Conversely,
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naïve PSCs are characterized by low active RHOA and high active RAC1 state and do not
exhibit the same pathway induced cell death. Further demonstrated, by this group, is the
dependency of ROCK activation on the chromosome 17 located gene, active BCR-related gene
(ABR). However, expression of ABR is positively correlated with ROCK activation and
inversely with RAC1 activation; therefore, a trisomy 17 overexpression is not consistent with
ABR as a functional candidate gene for selective advantage. They propose an upstream epiblast
state linked regulator that is an effector of both RHOA and RAC1 activation upon loss of Ecadherin based cell- cell contact [76]. Xu and colleagues show RHO signaling is regulated by Ecadherin based cell- cell contact and that naïve and primed PSCs have differential e-cadherin
turnover kinetics upon dissociation. MPSCs (???) have decreased intracellular cycling times and
cell surface re-expression of E-cadherin upon dissociation, conferring robust clonality to naïve
PSCs. Additionally, TZV, a ROCK inhibitor, was shown to increase stability of E-cadherin
expression upon dissociation induced turnover, suggesting an E-cadherin based mechanism to
this small molecule rather than by ROCK inhibition alone [45].

ARHGDIA is a RHO- GDP dissociation inhibitor that inhibits activation of members of
the RAS superfamily of G- proteins by preventing the exchange of GDP for GTP, thereby fixing
the inactive GDP bound state. ARHGDIA binds RHOA with high affinity and a long half- life
[206], as well as RAC1. Differential phosphorylation states for ARHGDIA and protein
expression levels have been proposed as mechanisms in regulation of RHO signaling [207].
ARHGDIA’s capacity to act on both RHOA and RAC1 is intriguing when considering a
molecular state associated with dissociation induced apoptosis. It has been shown that p21activated kinase (PAK1) phosphorylates ARHGDIA at serine 101 and serine 174 and in this
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particular state, ARHGDIA p101/174, tightly binds RHOA, stabilizing RHO- GDP inactive state
and dissociates from RAC1, allowing RAC1- GTP active state [208]. Also, Elfenbein and
colleagues have shown in HeLa cells that bFGF affects RHO signaling through phosphorylation
of ARHGDIA at serine 96 [209]. Therefore, we hypothesize that differential action of the
cytokines LIF and bFGF could influence the phosphorylation of ARHGDIA; thereby, affecting
naïve vs primed pluripotency via RHO signaling through differential regulation of the active
RHOA and RAC1 states. In future studies, we propose using mass spectrometry to profile the
phosphorylation states of ARHGDIA in hPSC culture, and in particular between our established
LIF-dependent hPSC and bFGF-dependent hPSC lines.

In our work, we observed the sufficiency of ARHGDIA overexpression to increase
single- cell survival and confer selective advantage in co-cultures with normal hPSCs. Our
preliminary data suggests that ARHGDIA overexpression is sufficient to reduce RHOA- GTP
levels (Figure 42). In trypsin dissociated H9 hPSCs, we observed reduced RHOA- GTP levels in
H9 (Arg) hPSCs relative to H9 (GFP) hPSCs. Initial samples were used to determine maximal
levels of RHOA- GTP in time series from 0- 30 minutes post- dissociation and plating. Building
on technical establishment of this assay in our laboratory, future studies will monitor both
RHOA- GTP and RAC1- GTP levels in dissociated hPSCs across ARHGDIA expression levels
and cytokine support.

The known biological roles for ARHGDIA are in the context of its action on RHO
GTPases; as such, ARHGDIA is a potential potent effector of cell- ECM adhesion, cell- cell
adhesion, and differentiation [207]. Indeed, we observed a pronounced morphological affect in
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our H9 hPSC line upon ARHGDIA overexpression. True hPSC clonal survival vs hPSC
migration promoted cell- cell contact have been established as independent mechanisms leading
to increased hPSC survival under single- cell plating [64]. ROCKi, Y27632, significantly
increases migration of hPSCs and could help explain its pro-survival affects for single- cells
[194]. The LN- 521 substrate has been demonstrated to promote single- cell survival through
migration; however, LN- 521 is insufficient to increase clonal survival. Recently, a LN-521/Ecadherin defined matrix was demonstrated to support clonal propagation of hPSCs in absence of
migration [64]. In contrast to Y27632’s null effect on E-cadherin, the small molecule, TZV,
increases stability of E-cadherin expression upon dissociation, suggesting an independent
mechanism involving E-cadherin based hPSC clonal survival. Active RAC1 has been shown to
positively influence E-cadherin cell adhesion strength in complex with IQGAP1 and catenin
[210]. When staining for F-actin, ARHGDIA overexpression did not induce the same
morphological influence as cells exposed to Y27632 (Figure 42A). The low seeding density of
100 cells/cm2 on iMEFs is suggestive that ARHGDIA overexpression impacted clonality rather
than by migration induced cell- cell contact. Further studies will look at the mechanisms by
which ARHGDIA overexpression confers selective advantage. In particular, the level of active
ROCK and phosphorylated MLC will be quantitated across ARHGDIA expression levels and
phosphorylation states. Initial results suggest, that upon dissociation, RHOA activation in
ARHGDIA overexpressing lines is less compared to control lines (Figure 43). The impact of
ARHGDIA expression on actin myosin contractile induced blebbing and on migration will also
be determined. Preliminary data from our laboratory demonstrates that turnover of E-cadherin
after trypsin digestion is linear (Figure 44) and that a positive correlation between ARHGDIA
expression and E-cadherin may exist (Figure 45 and Figure 46). A similar analysis, with TZV as
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a control, will be performed to determine whether increased ARHGDIA expression stabilizes Ecadherin expression reducing the turnover time after dissociation.

Reducing selective pressure for phenotypic advantage has been suggested as one
approach to reducing the rate of culture- induced genomic adaptation [200]. Anecdotal cases are
now emerging suggesting the impact of approaches improving clonality on reducing genomic
alterations in hPSC culture. Ware and colleagues compared their naïve- converted hPSC line
against a primed hPSC line. The naïve H1 hPSC line passaged by trypsin as single cells had a
normal karyotype at passage 93, while the companion primed H1 hPSC line had acquired
trisomy 12 and 17 [37]. Culture time to genomic alterations is highly variable and can easily take
months to observe, posing significant challenges to rigorous analysis of culture conditions
influencing selection of hPSC genomic variants. With the functional validation of ARHGDIA
conferring selective advantage and the development of our defined genetically engineered hPSC
lines, H9 (Arg) and BG01 (Arg), culture conditions can now be varied to assess influence of
selection forces.

The consequence of pluripotent state and dissociation induced apoptosis on scale- up is
significant. In one week, mPSCs with higher clonal survival and reduced cell cycle time [46],
can be expanded at two orders of magnitude greater than hPSCs, at 1000- fold for mPSCs
compared to 10 fold for hPSCs [43]. Additionally, with enzymatic passaging inducing a 2 fold
increase in genomic instability, improved culture for genomically stable propagation and scaleup is a pressing concern for research labs and industry when billions of cells are needed per
application [176]. The ground state of pluripotency is an attractive candidate for culture
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conditions improving stable propagation of genomically normal hPSCs and has several distinct
benefits compared to culture conditions developed for primed hPSCs. The ground state is
comprised of normal hPSCs that are clonal and have faster cell cycle times than primed hPSCs,
thereby implying that variants hPSCs will have a much steeper climb to gaining selective
advantage. Establishing the ground state in hPSCs may also have a significant biological
advantage for stable propagation by providing the most pristine pluripotent cells devoid of
selection, lineage bias, and as a pre- genomic self- correction in vivo analog. However with the
essential role of WNT signaling, GSK3 and-catenin, in maintaining the integrity of
centrosomes and chromosome segregation during mitosis, the debate between mutation and
selection is likely to remain unresolved, even as hPSC culture moves towards ground state
establishment for generation of genomically stable hPSCs for use in future regenerative
biomedical therapies.
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APPENDIX

Table 6 Primer Sequences for Self Renewal, Differentiation, and RHO signaling
Gene
Primers: 5' to 3'
Annotation
AFP F
CTTTGGGCTGCTCGCTATGA
Germ Layer
AFP R
GCATGTTGATTTAACAAGCTGCT
Germ Layer
Arhgdia- FP
GGATGAGCACTCGGTCAACTA
Rho Signaling
Arhgdia - RP
GGCCTCCTTGTACTTTCGCAG
Rho Signaling
GATA4 F
GTGTCCCAGACGTTCTCAGTC
Germ Layer
GATA4 R
GGGAGACGCATAGCCTTGT
Germ Layer
IGF2 F
TCCTCCCTGGACAATCAGAC
Germ Layer
IGF2 R
AGAAGCACCAGCATCGACTT
Germ Layer
Nanog F
Pluripotency
TTTGTGGGCCTGAAGAAAACT
Nanog R
AGGGCTGTCCTGAATAAGCAG
Pluripotency
Nestin F
CTGCTACCCTTGAGACACCTG
Germ Layer
Nestin R
GGGCTCTGATCTCTGCATCTAC
Germ Layer
OCT4 F
GGGAGATTGATAACTGGTGTGTT
Pluripotency
OCT4 R
GTGTATATCCCAGGGTGATCCTC
Pluripotency
SOX1 F
ATGCACCGCTACGACATGG
Germ Layer
SOX1 R
CTCATGTAGCCCTGCGAGTTG
Germ Layer
SOX2 FP
TACAGCATGTCCTACTCGCAG
Pluripotency
SOX2 RP
GAGGAAGAGGTAACCACAGGG
Pluripotency
T Brachyury F
TGCTTCCCTGAGACCCAGTT
Germ Layer
T Brachyury R
GATCACTTCTTTCCTTTGCATCAAG
Germ Layer
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Figure 37. ARHGDIA is a highly conserved protein across vertebrates. Multiple sequence
alignment was performed using Clustal X 2.1.
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Figure 38. Precision LentiORF lentiviral expression vector. Precision LentiORFs are human
cDNA open reading frames (ORFs) cloned into a lentiviral expression vector and used for
overexpressing human genes and proteins in mammalian cells. The experiment in this study
expressed ARHGDIA. Sourced from GE Healthcare.
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Figure 39. Heterogeneous metastable states of hPSCs cultured in LIF + 2i medium exhibit
differentiation and self- renewal. Within a colony some cells self- renew and some differentiate
(white arrow) suggesting the coexistence of cells that are LIF- responsive and indicative of naïve
PSCs and some cells that are prone to differentiation. BG01 (LIF) at p+1 (A) and BG01 (LIF) at
p+15 (B). Magnification is 4x.
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Figure 40. Heterogeneous OCT4 expression in BG01 (LIF) manually passaged cultures.
Within a colony, cells exhibit differential likelihood of self- renewal. OCT4 is known to persist
in initial stages of differentiation, however this suggest that OCT4 is a sensitive marker and that
hPSC (LIF) are prone to down regulation of OCT4. BG01 (LIF) at p+17. Scale bar = 50 m.
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Figure 41. Embryoid bodies generated from H9 hPSCs propagated on MatrigelTM and
iMEFs in LIF +2i medium. H9 (LIF + 2i) lines grown on iMEFs exhibit irregular shape and
poor density (A&B). H9 (LIF + 2i) grown on MatrigelTM are dense and symmetrical (C & D). 10
mM ROCKi used at the initial hanging drop step. Magnification 4x = A, C; 10x= B, D.
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Figure 42. ROCKi, Y27632, inhibits cell- cell contact within hPSC colonies. Phalloidin is
stained to visualize F- actin. BG01 (Arg) with 0 M ROCKi (A), BG01 (WT) with 0 M ROCKi
(B), and BG01 (WT) with 10 ROCKi for 24 hours (C). In the ROCKi exposed sample the
cytoskeleton is retracted and there is loss of cell- cell contact (white arrows). Scale bar= 50 m
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Figure 43. RHOA activation is inhibited in hPSCs overexpressing ARHGDIA. H9 (Arg) is
compared to matched controls H9 (GFP). Basal (adherent) expression is less in the H9 (Arg)
line. 15 minutes post- trypsinization and plating RHOA is activated in the H9 (GFP) sample;
however to a lesser extent is RHOA activated upon trypsinization in the H9 (Arg) line. Upon
trypsinization total active RHOA is less in the H9 (Arg) line. RHOA activation was determined
using the G- Lisa kit from Cytoskelton, Inc. for the antibody RHOA- GTP.
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Figure 44. E-cadherin turnover is linear after single- cell dissociation by trypsin. E-cadherin
(upper band) and B-tubulin (lower band). H9 hPSC line was dissociated using 0.05% trypsin.
Full length E-cadherin is cleaved after dissociation and is linearly increased to near basal levels
by 8 hours.
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Figure 45. E- cadherin expression is correlated with Arhgdia expression levels. The H9(v),
H9 (Arg), BG01(v), and BG01 (Arg) have increased protein expression of ARHGDIA and Ecadherin as determined by Western Analysis. H9(v) has trisomy 17 and BG01(v) has trisomy 17
and complex karyotype. All other samples are euploid.

165

Figure 46. IPSC(v) overexpresses E-cadherin. iPSC(v) with trisomy 17 and X has increased Ecadherin protein expression relative to euploid iPSC, as determined by Western Analysis.
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